{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:51:06Z","timestamp":1792245066376,"version":"4.4.0"},"reference-count":294,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10741-018-9716-x","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:51:41Z","timestamp":1528073501000},"page":"733-758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":271,"title":["Role of cytokines and inflammation in heart function during health and disease"],"prefix":"10.1007","volume":"23","author":[{"given":"Monika","family":"Bartekova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Radosinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Jelemensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naranjan S","family":"Dhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"key":"9716_CR1","unstructured":"Lackie J (2010) A dictionary of biomedicine. Oxford University Press, ISBN-9780199549351"},{"key":"9716_CR2","unstructured":"Cohen S (1989) Lymphokines and the immune response. CRC Press, USA, ISBN-0-8493-6427-2"},{"key":"9716_CR3","first-page":"298","volume":"15","author":"JG Cannon","year":"2000","unstructured":"Cannon JG (2000) Inflammatory cytokines in non-pathological states. News Physiol Sci 15:298\u2013303","journal-title":"News Physiol Sci"},{"issue":"4","key":"9716_CR4","first-page":"213","volume":"10","author":"HK Saini","year":"2005","unstructured":"Saini HK, Xu Y-J, Zhang M, Liu PP, Kirshenbaum LA, Dhalla NS (2005) Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart. Exp Clin Cardiol 10(4):213\u2013222","journal-title":"Exp Clin Cardiol"},{"key":"9716_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF01816946","volume":"143","author":"RR Padua","year":"1995","unstructured":"Padua RR, Sethi R, Dhalla NS, Kardami E (1995) Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol Cell Biochem 143:129\u2013135","journal-title":"Mol Cell Biochem"},{"issue":"9270","key":"9716_CR6","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","volume":"357","author":"J Parkin","year":"2001","unstructured":"Parkin J, Cohen B (2001) An overview of the immune system. Lancet 357(9270):1777\u20131789","journal-title":"Lancet"},{"issue":"5","key":"9716_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signaling. Nat Rev Immunol 5(5):375\u2013386","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"9716_CR8","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.4049\/jimmunol.179.7.4307","volume":"179","author":"M Sun","year":"2007","unstructured":"Sun M, Fink PJ (2007) A new class of reverse signaling costimulators belongs to the TNF family. J Immunol 179(7):4307\u20134312","journal-title":"J Immunol"},{"issue":"3 Pt 2","key":"9716_CR9","first-page":"H901","volume":"276","author":"D Beasley","year":"1999","unstructured":"Beasley D, Cooper AL (1999) Constitutive expression of interleukin-1alpha precursor promotes human vascular smooth muscle cell proliferation. Am J Phys 276(3 Pt 2):H901\u2013H912","journal-title":"Am J Phys"},{"issue":"3","key":"9716_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0167-4889(02)00316-6","volume":"1592","author":"J Gr\u00f6tzinger","year":"2002","unstructured":"Gr\u00f6tzinger J (2002) Molecular mechanisms of cytokine receptor activation. Biochim Biophys Acta 1592(3):215\u2013223","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"9716_CR11","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1021\/acs.jmedchem.6b01309","volume":"60","author":"M Arimont","year":"2017","unstructured":"Arimont M, Sun SL, Leurs R, Smit M, de Esch IJP, de Graaf C (2017) Structural analysis of chemokine receptor-ligand interactions. J Med Chem 60(12):4735\u20134779","journal-title":"J Med Chem"},{"issue":"2","key":"9716_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jlb.64.2.135","volume":"64","author":"ML Heaney","year":"1998","unstructured":"Heaney ML, Golde DW (1998) Soluble receptors in human disease. J Leukoc Biol 64(2):135\u2013146","journal-title":"J Leukoc Biol"},{"issue":"3","key":"9716_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0735-1097(99)00600-2","volume":"35","author":"AM Feldman","year":"2000","unstructured":"Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C (2000) The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 35(3):537\u2013544","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"9716_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0735-1097(01)01377-8","volume":"38","author":"G Valen","year":"2001","unstructured":"Valen G, Yan ZQ, Hansson GK (2001) Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38(2):307\u2013314","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"9716_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2567.2006.02336.x","volume":"118","author":"R Khan","year":"2006","unstructured":"Khan R, Sheppard R (2006) Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 118(1):10\u201324","journal-title":"Immunology"},{"issue":"3","key":"9716_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132(3):344\u2013362","journal-title":"Cell"},{"key":"9716_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.critrevonc.2017.11.001","volume":"120","author":"S Tilborghs","year":"2017","unstructured":"Tilborghs S, Corthouts J, Verhoeven Y, Arias D, Rolfo C, Trinh XB, van Dam PA (2017) The role of nuclear factor-kappa B signaling in human cervical cancer. Crit Rev Oncol Hematol 120:141\u2013150","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"9716_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-065X.2011.01088.x","volume":"246","author":"SC Sun","year":"2012","unstructured":"Sun SC (2012) The noncanonical NF-\u03baB pathway. Immunol Rev 246(1):125\u2013140","journal-title":"Immunol Rev"},{"issue":"3","key":"9716_CR19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1128\/CMR.15.3.414-429.2002","volume":"15","author":"J Caama\u00f1o","year":"2002","unstructured":"Caama\u00f1o J, Hunter CA (2002) NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev 15(3):414\u2013129","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"9716_CR20","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","volume":"108","author":"JW Gordon","year":"2011","unstructured":"Gordon JW, Shaw JA, Kirshenbaum LA (2011) Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB. Circ Res 108(9):1122\u20131132","journal-title":"Circ Res"},{"issue":"25","key":"9716_CR21","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1161\/01.CIR.0000150537.59754.55","volume":"110","author":"KM Regula","year":"2004","unstructured":"Regula KM, Baetz D, Kirshenbaum LA (2004) Nuclear factor-kappaB represses hypoxia-induced mitochondrial defects and cell death of ventricular myocytes. Circulation 110(25):3795\u20133802","journal-title":"Circulation"},{"issue":"2","key":"9716_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3892\/mmr.2014.2292","volume":"10","author":"XY Wu","year":"2014","unstructured":"Wu XY, Luo AY, Zhou YR, Ren JH (2014) N-acetylcysteine reduces oxidative stress, nuclear facto-\u03baB activity and cardiomyocyte apoptosis in heart failure. Mol Med Rep 10(2):615\u2013624","journal-title":"Mol Med Rep"},{"issue":"5","key":"9716_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3109\/10253890.2011.571729","volume":"14","author":"RP Wang","year":"2011","unstructured":"Wang RP, Yao Q, Xiao YB, Zhu SB, Yang L, Feng JM, Li DZ, Li XL, Wu JJ, Chen J (2011) Toll-like receptor 4\/nuclear factor-kappa B pathway is involved in myocardial injury in a rat chronic stress model. Stress 14(5):567\u2013575","journal-title":"Stress"},{"issue":"3","key":"9716_CR24","doi-asserted-by":"publisher","first-page":"H919","DOI":"10.1152\/ajpheart.00851.2002","volume":"284","author":"J Pye","year":"2003","unstructured":"Pye J, Ardeshirpour F, McCain A, Bellinger DA, Merricks E, Adams J, Elliott PJ, Pien C, Fischer TH, Baldwin AS Jr, Nichols TC (2003) Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am J Physiol Heart Circ Physiol 284(3):H919\u2013H926","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"9716_CR25","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1096\/fj.05-5133fje","volume":"20","author":"S Frantz","year":"2006","unstructured":"Frantz S, Hu K, Bayer B, Gerondakis S, Strotmann J, Adamek A, Ertl G, Bauersachs J (2006) Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction. FASEB J 20(11):1918\u20131920","journal-title":"FASEB J"},{"key":"9716_CR26","doi-asserted-by":"publisher","first-page":"H2248","DOI":"10.1152\/ajpheart.00776.2007","volume":"293","author":"NC Moss","year":"2007","unstructured":"Moss NC, Stansfield WE, Willis MS, Tang RH, Selzman CH (2007) IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 293:H2248\u2013H2253","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"15","key":"9716_CR27","first-page":"2103","volume":"17","author":"CC Liu","year":"2013","unstructured":"Liu CC, Huang Y, Zhang JH, Xu Y, Wu CH (2013) Effect of carvedilol on cardiac dysfunction 4 days after myocardial infarction in rats: role of toll-like receptor 4 and \u03b2-arrestin 2. Eur Rev Med Pharmacol Sci 17(15):2103\u20132110","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"9716_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5830\/CVJA-2014-038","volume":"25","author":"O Burma","year":"2014","unstructured":"Burma O, Onat E, Uysal A, Ilhan N, Erol D, Ozcan M, Sahna E (2014) Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion. Cardiovasc J Afr 25(5):212\u2013216","journal-title":"Cardiovasc J Afr"},{"issue":"1","key":"9716_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/CIRCHEARTFAILURE.109.899732","volume":"3","author":"JS Burchfield","year":"2010","unstructured":"Burchfield JS, Dong JW, Sakata Y, Gao F, Tzeng HP, Topkara VK, Entman ML, Sivasubramanian N, Mann DL (2010) The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart. Circ Heart Fail 3(1):157\u2013164","journal-title":"Circ Heart Fail"},{"key":"9716_CR30","doi-asserted-by":"publisher","first-page":"e000662","DOI":"10.1161\/JAHA.113.000662","volume":"3","author":"HP Tzeng","year":"2014","unstructured":"Tzeng HP, Evans S, Gao F, Chambers K, Topkara VK, Sivasubramanian N, Barger PM, Mann DL (2014) Dysferlin mediates the cytoprotective effects of TRAF2 following myocardial ischemia reperfusion injury. J Am Heart Assoc 3:e000662","journal-title":"J Am Heart Assoc"},{"issue":"25","key":"9716_CR31","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1161\/01.CIR.0000108929.93074.0B","volume":"108","author":"A Misra","year":"2003","unstructured":"Misra A, Haudek SB, Knuefermann P, Vallejo JG, Chen ZJ, Michael LH, Sivasubramanian N, Olson EN, Entman ML, Mann DL (2003) Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Circulation 108(25):3075\u20133078","journal-title":"Circulation"},{"issue":"2","key":"9716_CR32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bbrc.2015.09.171","volume":"467","author":"A D\u00edaz","year":"2015","unstructured":"D\u00edaz A, Humeres C, Gonz\u00e1lez V, G\u00f3mez MT, Montt N, Sanchez G, Chiong M, Garc\u00eda L (2015) Insulin\/NF\u03baB protects against ischemia-induced necrotic cardiomyocyte death. Biochem Biophys Res Commun 467(2):451\u2013457","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"9716_CR33","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jnutbio.2015.06.006","volume":"26","author":"PK Bagul","year":"2015","unstructured":"Bagul PK, Deepthi N, Sultana R, Banerjee SK (2015) Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3. J Nutr Biochem 26(11):1298\u20131307","journal-title":"J Nutr Biochem"},{"issue":"5","key":"9716_CR34","doi-asserted-by":"publisher","first-page":"e94228","DOI":"10.1371\/journal.pone.0094228","volume":"9","author":"R Padiya","year":"2014","unstructured":"Padiya R, Chowdhury D, Borkar R, Srinivas R, Pal Bhadra M, Banerjee SK (2014) Garlic attenuates cardiac oxidative stress via activation of PI3K\/AKT\/Nrf2-Keap1 pathway in fructose-fed diabetic rat. PLoS One 9(5):e94228","journal-title":"PLoS One"},{"issue":"1","key":"9716_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-0043-106859","volume":"126","author":"MAE Wassef","year":"2018","unstructured":"Wassef MAE, Tork OM, Rashed LA, Ibrahim W, Morsi H, Rabie DMM (2018) Mitochondrial dysfunction in diabetic cardiomyopathy: effect of mesenchymal stem cell with PPAR-\u03b3 agonist or exendin-4. Exp Clin Endocrinol Diabetes 126(1):27\u201338","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"9716_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2174\/1570161114666161025101303","volume":"15","author":"A Jovanovic","year":"2017","unstructured":"Jovanovic A, Sudar-Milovanovic E, Obradovic M, Pitt SJ, Stewart AJ, Zafirovic S, Stanimirovic J, Radak D, Isenovic ER (2017) Influence of a high-fat diet on cardiac iNOS in female rats. Curr Vasc Pharmacol 15(5):491\u2013500","journal-title":"Curr Vasc Pharmacol"},{"issue":"10","key":"9716_CR37","doi-asserted-by":"publisher","first-page":"e0165406","DOI":"10.1371\/journal.pone.0165406","volume":"11","author":"KH Lin","year":"2016","unstructured":"Lin KH, Liu CL, Kuo WW, Paul CR, Chen WK, Wen SY, Day CH, Wu HC, Viswanadha VP, Huang CY (2016) Early fluid resuscitation by lactated Ringer\u2019s solution alleviate the cardiac apoptosis in rats with trauma-hemorrhagic shock. PLoS One 11(10):e0165406","journal-title":"PLoS One"},{"key":"9716_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.yjmcc.2014.06.018","volume":"75","author":"H Huang","year":"2014","unstructured":"Huang H, Joseph LC, Gurin MI, Thorp EB, Morrow JP (2014) Extracellular signal-regulated kinase activation during cardiac hypertrophy reduces sarcoplasmic\/endoplasmic reticulum calcium ATPase 2 (SERCA2) transcription. J Mol Cell Cardiol 75:58\u201363","journal-title":"J Mol Cell Cardiol"},{"key":"9716_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.exger.2015.11.005","volume":"73","author":"K Forman","year":"2016","unstructured":"Forman K, Vara E, Garc\u00eda C, Kireev R, Cuesta S, Acu\u00f1a-Castroviejo D, Tresguerres JA (2016) Influence of aging and growth hormone on different members of the NFkB family and IkB expression in the heart from a murine model of senescence-accelerated aging. Exp Gerontol 73:114\u2013120","journal-title":"Exp Gerontol"},{"key":"9716_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1471-2350-11-89","volume":"11","author":"DG Santos","year":"2010","unstructured":"Santos DG, Resende MF, Mill JG, Mansur AJ, Krieger JE, Pereira AC (2010) Nuclear factor (NF) kappa B polymorphism is associated with heart function in patients with heart failure. BMC Med Genet 11:89","journal-title":"BMC Med Genet"},{"issue":"3","key":"9716_CR41","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.cyto.2012.12.020","volume":"61","author":"A Mishra","year":"2013","unstructured":"Mishra A, Srivastava A, Mittal T, Garg N, Mittal B (2013) Role of inflammatory gene polymorphisms in left ventricular dysfunction (LVD) susceptibility in coronary artery disease (CAD) patients. Cytokine 61(3):856\u2013861","journal-title":"Cytokine"},{"issue":"1","key":"9716_CR42","doi-asserted-by":"publisher","first-page":"H743","DOI":"10.1152\/ajpheart.00166.2007","volume":"293","author":"Y Monden","year":"2007","unstructured":"Monden Y, Kubota T, Inoue T, Tsutsumi T, Kawano S, Ide T, Tsutsui H, Sunagawa K (2007) Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction. Am J Physiol Heart Circ Physiol 293(1):H743\u2013H753","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"9716_CR43","first-page":"5063","volume":"9","author":"L Fang","year":"2017","unstructured":"Fang L, Ellims AH, Beale AL, Taylor AJ, Murphy A, Dart AM (2017) Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy. Am J Transl Res 9(11):5063\u20135073","journal-title":"Am J Transl Res"},{"key":"9716_CR44","doi-asserted-by":"publisher","unstructured":"Eskandari V, Amirzargar AA, Mahmoudi MJ, Rahnemoon Z, Rahmani F, Sadati S, Rahmati Z, Gorzin F, Hedayat M, Rezaei N (2017) Gene expression and levels of IL-6 and TNF\u03b1 in PBMCs correlate with severity and functional class in patients with chronic heart failure. Ir J Med Sci. https:\/\/doi.org\/10.1007\/s11845-017-1680-2","DOI":"10.1007\/s11845-017-1680-2"},{"issue":"3","key":"9716_CR45","doi-asserted-by":"publisher","first-page":"H960","DOI":"10.1152\/ajpheart.0718.2001","volume":"284","author":"AM Janczewski","year":"2003","unstructured":"Janczewski AM, Kadokami T, Lemster B, Frye CS, McTiernan CF, Feldman AM (2003) Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha. Am J Physiol Heart Circ Physiol 284(3):H960\u2013H969","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"9716_CR46","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/01.CIR.0000085203.46621.F4","volume":"108","author":"ZI Dibbs","year":"2003","unstructured":"Dibbs ZI, Diwan A, Nemoto S, DeFreitas G, Abdellatif M, Carabello BA, Spinale FG, Feuerstein G, Sivasubramanian N, Mann DL (2003) Targeted overexpression of transmembrane tumor necrosis factor provokes a concentric cardiac hypertrophic phenotype. Circulation 108(8):1002\u20131008","journal-title":"Circulation"},{"issue":"4","key":"9716_CR47","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","volume":"51","author":"M Dobaczewski","year":"2011","unstructured":"Dobaczewski M, Chen W, Frangogiannis NG (2011) Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling. J Mol Cell Cardiol 51(4):600\u2013606","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"9716_CR48","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI94753","volume":"127","author":"H Khalil","year":"2017","unstructured":"Khalil H, Kanisicak O, Prasad V, Correll RN, Fu X, Schips T, Vagnozzi RJ, Liu R, Huynh T, Lee SJ, Karch J, Molkentin JD (2017) Fibroblast-specific TGF-\u03b2-Smad2\/3 signaling underlies cardiac fibrosis. J Clin Invest 127(10):3770\u20133783","journal-title":"J Clin Invest"},{"issue":"6","key":"9716_CR49","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1536\/ihj.16-572","volume":"58","author":"Z Ding","year":"2017","unstructured":"Ding Z, Yuan J, Liang Y, Wu J, Gong H, Ye Y, Jiang G, Yin P, Li Y, Zhang G, Yang C, Guo J, Chen Z, Wang X, Weng L, Zou Y (2017) Ryanodine receptor type 2 plays a role in the development of cardiac fibrosis under mechanical stretch through TGF\u03b2-1. Int Heart J 58(6):957\u2013961","journal-title":"Int Heart J"},{"issue":"3","key":"9716_CR50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jash.2010.02.007","volume":"4","author":"JL Almendral","year":"2010","unstructured":"Almendral JL, Shick V, Rosendorff C, Atlas SA (2010) Association between transforming growth factor-beta(1) and left ventricular mass and diameter in hypertensive patients. J Am Soc Hypertens 4(3):135\u2013141","journal-title":"J Am Soc Hypertens"},{"issue":"1","key":"9716_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1161\/01.RES.75.1.23","volume":"75","author":"MO Boluyt","year":"1994","unstructured":"Boluyt MO, O'Neill L, Meredith AL, Bing OH, Brooks WW, Conrad CH, Crow MT, Lakatta EG (1994) Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components. Circ Res 75(1):23\u201332","journal-title":"Circ Res"},{"issue":"6","key":"9716_CR52","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/clc.22404","volume":"38","author":"B Ay\u00e7a","year":"2015","unstructured":"Ay\u00e7a B, Sahin I, Kucuk SH, Akin F, Kafadar D, Av\u015far M, Avci II, Gungor B, Okuyan E, Dinckal MH (2015) Increased transforming growth factor-\u03b2 levels associated with cardiac adverse events in hypertrophic cardiomyopathy. Clin Cardiol 38(6):371\u2013377","journal-title":"Clin Cardiol"},{"issue":"22","key":"9716_CR53","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1161\/CIRCULATIONAHA.104.510354","volume":"111","author":"NG Frangogiannis","year":"2005","unstructured":"Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J, Entman ML (2005) Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 111(22):2935\u20132942","journal-title":"Circulation"},{"issue":"4","key":"9716_CR54","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/icvts\/ivx153","volume":"25","author":"C Rueda-Mart\u00ednez","year":"2017","unstructured":"Rueda-Mart\u00ednez C, Lamas O, Carrasco-Chinchilla F, Robledo-Carmona J, Porras C, S\u00e1nchez-Esp\u00edn G, Navarro MJ, Fern\u00e1ndez B (2017) Increased blood levels of transforming growth factor \u03b2 in patients with aortic dilatation. Interact Cardiovasc Thorac Surg 25(4):571\u2013574","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"3 Pt 2","key":"9716_CR55","first-page":"R577","volume":"274","author":"DR Meldrum","year":"1998","unstructured":"Meldrum DR (1998) Tumor necrosis factor in the heart. Am J Phys 274(3 Pt 2):R577\u2013R595","journal-title":"Am J Phys"},{"key":"9716_CR56","doi-asserted-by":"publisher","unstructured":"Jarrah AA, Schwarskopf M, Wang ER, LaRocca T, Dhume A, Zhang S, Hadri L, Hajjar RJ, Schecter AD, Tarzami ST (2017) SDF-1 induces TNF-mediated apoptosis in cardiac myocytes. Apoptosis. https:\/\/doi.org\/10.1007\/s10495-017-1438-3","DOI":"10.1007\/s10495-017-1438-3"},{"issue":"1","key":"9716_CR57","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cdtm.2015.02.002","volume":"1","author":"M Tian","year":"2015","unstructured":"Tian M, Yuan YC, Li JY, Gionfriddo MR, Huang RC (2015) Tumor necrosis factor-\u03b1 and its role as a mediator in myocardial infarction: a brief review. Chronic Dis Transl Med 1(1):18\u201326","journal-title":"Chronic Dis Transl Med"},{"issue":"2","key":"9716_CR58","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/path.4187","volume":"230","author":"JP Waters","year":"2013","unstructured":"Waters JP, Pober JS, Bradley JR (2013) Tumour necrosis factor in infectious disease. J Pathol 230(2):132\u2013147","journal-title":"J Pathol"},{"issue":"2","key":"9716_CR59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.phrs.2008.06.007","volume":"58","author":"NG Frangogiannis","year":"2008","unstructured":"Frangogiannis NG (2008) The immune system and cardiac repair. Pharmacol Res 58(2):88\u2013111","journal-title":"Pharmacol Res"},{"issue":"6","key":"9716_CR60","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10741-010-9168-4","volume":"15","author":"M Hedayat","year":"2010","unstructured":"Hedayat M, Mahmoudi MJ, Rose NR, Rezaei N (2010) Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev 15(6):543\u2013562","journal-title":"Heart Fail Rev"},{"issue":"10","key":"9716_CR61","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1161\/CIRCULATIONAHA.108.802918","volume":"119","author":"T Hamid","year":"2009","unstructured":"Hamid T, Gu Y, Ortines RV, Bhattacharya C, Wang G, Xuan YT, Prabhu SD (2009) Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation. Circulation 119(10):1386\u20131397","journal-title":"Circulation"},{"issue":"15","key":"9716_CR62","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1161\/01.CIR.0000124227.00670.AB","volume":"109","author":"Y Higuchi","year":"2004","unstructured":"Higuchi Y, McTiernan CF, Frye CB, McGowan BS, Chan TO, Feldman AM (2004) Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy. Circulation 109(15):1892\u20131897","journal-title":"Circulation"},{"key":"9716_CR63","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1126\/science.1631560","volume":"257","author":"MS Finkel","year":"1992","unstructured":"Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387\u2013389","journal-title":"Science"},{"key":"9716_CR64","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1172\/JCI116834","volume":"92","author":"T Yokoyama","year":"1993","unstructured":"Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL (1993) Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 92:2303\u20132312","journal-title":"J Clin Invest"},{"issue":"4","key":"9716_CR65","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1056\/NEJM199007263230405","volume":"323","author":"B Levine","year":"1990","unstructured":"Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323(4):236\u2013241","journal-title":"N Engl J Med"},{"issue":"4","key":"9716_CR66","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1161\/01.CIR.93.4.704","volume":"93","author":"G Torre-Amione","year":"1996","unstructured":"Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL (1996) Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93(4):704\u2013711","journal-title":"Circulation"},{"key":"9716_CR67","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.cardiores.2006.12.016","volume":"73","author":"Y Monden","year":"2007","unstructured":"Monden Y, Kubota T, Tsutsumi T, Inoue T, Kawano S, Kawamura N, Ide T, Egashira K, Tsutsui H, Sunagawa K (2007) Soluble TNF receptors prevent apoptosis in infiltrating cells and promote ventricular rupture and remodeling after myocardial infarction. Cardiovasc Res 73:794\u2013805","journal-title":"Cardiovasc Res"},{"key":"9716_CR68","doi-asserted-by":"publisher","first-page":"5456","DOI":"10.1073\/pnas.070036297","volume":"97","author":"KM Kurrelmeyer","year":"2000","unstructured":"Kurrelmeyer KM, Michael LH, Baumgarten G, Taffet GE, Peschon JJ, Sivasubramanian N, Entman ML, Mann DL (2000) Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A 97:5456\u20135461","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"9716_CR69","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/01.CIR.97.14.1392","volume":"97","author":"M Nakano","year":"1998","unstructured":"Nakano M, Knowlton AA, Dibbs Z, Mann DL (1998) Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte. Circulation 97(14):1392\u20131400","journal-title":"Circulation"},{"issue":"7","key":"9716_CR70","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/01.CIR.0000155614.35441.69","volume":"111","author":"M Valgimigli","year":"2005","unstructured":"Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, Francolini G, Cicchitelli G, Olivares A, Parrinello G, Percoco G, Guardigli G, Mele D, Pirani R, Ferrari R (2005) Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation 111(7):863\u2013870","journal-title":"Circulation"},{"issue":"2","key":"9716_CR71","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1536\/ihj.16-236","volume":"58","author":"Z Ping","year":"2017","unstructured":"Ping Z, Aiqun M, Jiwu L, Liang S (2017) TNF receptor 1\/2 predict heart failure risk in type 2 diabetes mellitus patients. Int Heart J 58(2):245\u2013249","journal-title":"Int Heart J"},{"issue":"9","key":"9716_CR72","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1172\/JCI29134","volume":"117","author":"SB Haudek","year":"2007","unstructured":"Haudek SB, Taffet GE, Schneider MD, Mann DL (2007) TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J Clin Invest 117(9):2692\u20132701","journal-title":"J Clin Invest"},{"issue":"12","key":"9716_CR73","doi-asserted-by":"publisher","first-page":"e004252","DOI":"10.1161\/CIRCHEARTFAILURE.117.004252","volume":"10","author":"J Hartupee","year":"2017","unstructured":"Hartupee J, Szalai GD, Wang W, Ma X, Diwan A, Mann DL (2017) Impaired protein quality control during left ventricular remodeling in mice with cardiac restricted overexpression of tumor necrosis factor. Circ Heart Fail 10(12):e004252","journal-title":"Circ Heart Fail"},{"issue":"7","key":"9716_CR74","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1161\/hc3401.093154","volume":"104","author":"N Sivasubramanian","year":"2001","unstructured":"Sivasubramanian N, Coker ML, Kurrelmeyer KM, MacLellan WR, DeMayo FJ, Spinale FG, Mann DL (2001) Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104(7):826\u2013831","journal-title":"Circulation"},{"key":"9716_CR75","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cyto.2017.11.015","volume":"107","author":"B Jude","year":"2018","unstructured":"Jude B, Vetel S, Giroux-Metges MA, Pennec JP (2018) Rapid negative inotropic effect induced by TNF-\u03b1 in rat heart perfused related to PKC activation. Cytokine 107:65\u201369","journal-title":"Cytokine"},{"issue":"3","key":"9716_CR76","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm1000","volume":"10","author":"JC Braz","year":"2004","unstructured":"Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, Bodi I, Wang S, Schwartz A, Lakatta EG, DePaoli-Roach AA, Robbins J, Hewett TE, Bibb JA, Westfall MV, Kranias EG, Molkentin JD (2004) PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 10(3):248\u2013254","journal-title":"Nat Med"},{"issue":"3","key":"9716_CR77","doi-asserted-by":"publisher","first-page":"H782","DOI":"10.1152\/ajpheart.00817.2010","volume":"302","author":"H Hallaq","year":"2012","unstructured":"Hallaq H, Wang DW, Kunic JD, George AL Jr, Wells KS, Murray KT (2012) Activation of protein kinase C alters the intracellular distribution and mobility of cardiac Na+ channels. Am J Physiol Heart Circ Physiol 302(3):H782\u2013H789","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"9716_CR78","doi-asserted-by":"publisher","first-page":"C1477","DOI":"10.1152\/ajpcell.2001.281.5.C1477","volume":"281","author":"GQ Xiao","year":"2001","unstructured":"Xiao GQ, Qu Y, Sun ZQ, Mochly-Rosen D, Boutjdir M (2001) Evidence for functional role of epsilonPKC isozyme in the regulation of cardiac Na(+) channels. Am J Phys Cell Phys 281(5):C1477\u2013C1486","journal-title":"Am J Phys Cell Phys"},{"issue":"3","key":"9716_CR79","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1161\/01.RES.81.3.380","volume":"81","author":"CL Watson","year":"1997","unstructured":"Watson CL, Gold MR (1997) Modulation of Na+ current inactivation by stimulation of protein kinase C in cardiac cells. Circ Res 81(3):380\u2013386","journal-title":"Circ Res"},{"issue":"4","key":"9716_CR80","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ceca.2010.02.002","volume":"47","author":"DJ Duncan","year":"2010","unstructured":"Duncan DJ, Yang Z, Hopkins PM, Steele DS, Harrison SM (2010) TNF-alpha and IL-1beta increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes. Cell Calcium 47(4):378\u2013386","journal-title":"Cell Calcium"},{"issue":"3","key":"9716_CR81","doi-asserted-by":"publisher","first-page":"160","DOI":"10.15441\/ceem.17.220","volume":"4","author":"JH Lee","year":"2017","unstructured":"Lee JH, Lee TK, Kim IH, Lee JC, Won MH, Park JH, Ahn JH, Shin MC, Ohk TG, Moon JB, Cho JH, Park CW, Tae HJ (2017) Changes in histopathology and tumor necrosis factor-\u03b1 levels in the hearts of rats following asphyxial cardiac arrest. Clin Exp Emerg Med 4(3):160\u2013167","journal-title":"Clin Exp Emerg Med"},{"key":"9716_CR82","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11010-012-1447-z","volume":"372","author":"AAR Al-Shudiefat","year":"2013","unstructured":"Al-Shudiefat AAR, Sharma AK, Bagchi AK, Dhingra S, Singal PK (2013) Oleic acid mitigates TNF-\u03b1-induced oxidative stress in rat cardiomyocytes. Mol Cell Biochem 372:75\u201382","journal-title":"Mol Cell Biochem"},{"key":"9716_CR83","first-page":"146","volume":"7","author":"SS Rathi","year":"2002","unstructured":"Rathi SS, Xu Y-J, Dhalla NS (2002) Mechanism of cardioprotective action of TNF-\u03b1 in the isolated rat heart. Exp Clin Cardiol 7:146\u2013150","journal-title":"Exp Clin Cardiol"},{"key":"9716_CR84","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbrc.2004.11.131","volume":"327","author":"M Zhang","year":"2005","unstructured":"Zhang M, Xu Y-J, Saini HK, Turan B, Liu PP, Dhalla NS (2005) TNF-\u03b1 as a potential mediator of cardiac dysfunction due to intracellular Ca2+-overload. Biochem Biophys Res Commun 327:57\u201363","journal-title":"Biochem Biophys Res Commun"},{"key":"9716_CR85","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1089\/ars.2005.7.1388","volume":"7","author":"B Turan","year":"2005","unstructured":"Turan B, Saini HK, Zhang M, Prajapati D, Elimban V, Dhalla NS (2005) Selenium improves cardiac function by attenuating the activation of NF-\u03baB due to ischemia-reperfusion injury. Antioxid Redox Signal 7:1388\u20131397","journal-title":"Antioxid Redox Signal"},{"key":"9716_CR86","doi-asserted-by":"publisher","first-page":"H832","DOI":"10.1152\/ajpheart.00178.2005","volume":"289","author":"M Zhang","year":"2005","unstructured":"Zhang M, Xu Y-J, Saini HK, Turan B, Liu PP, Dhalla NS (2005) Pentoxifylline attenuates cardiac dysfunction and reduces TNF-\u03b1 level in the ischemic-reperfused heart. Am J Physiol Heart Circ Physiol 289:H832\u2013H839","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9716_CR87","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1111\/j.1582-4934.2009.00904.x","volume":"14","author":"S Das","year":"2010","unstructured":"Das S, Babick AP, Xu Y-J, Takeda N, Rodriguez-Leyva D, Dhalla NS (2010) TNF-\u03b1 mediated signal transduction pathway is a major determinant of apoptosis in dilated cardiomyopathy. J Cell Mol Med 14:1988\u20131997","journal-title":"J Cell Mol Med"},{"key":"9716_CR88","doi-asserted-by":"crossref","unstructured":"Saghebjoo M, Nezamdoost Z, Ahmadabadi F, Saffari I, Hamidi A (2017) The effect of 12 weeks of aerobic training on serum levels high sensitivity C-reactive protein, tumor necrosis factor-alpha, lipid profile and anthropometric characteristics in middle-age women patients with type 2 diabetes. Diabetes Metab Syndr S1871-4021(17)30379-X.","DOI":"10.1016\/j.dsx.2017.12.008"},{"issue":"4","key":"9716_CR89","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.4314\/ahs.v15i4.13","volume":"15","author":"SM Abd El-Kader","year":"2015","unstructured":"Abd El-Kader SM, Al-Jiffri OH, Al-Shreef FM (2015) Aerobic exercises alleviate symptoms of fatigue related to inflammatory cytokines in obese patients with type 2 diabetes. Afr Health Sci 15(4):1142\u20131148","journal-title":"Afr Health Sci"},{"key":"9716_CR90","unstructured":"Silva SD Jr, Jara ZP, Peres R, Lima LS, Scavone C, Montezano AC, Touyz RM, Casarini DE, Michelini LC (2017) Temporal changes in cardiac oxidative stress, inflammation and remodeling induced by exercise in hypertension: role for local angiotensin II reduction. PLoS One 12(12):e0189535."},{"key":"9716_CR91","doi-asserted-by":"publisher","unstructured":"Windsor MT, Bailey TG, Perissiou M, Greaves K, Jha P, Leicht AS, Russell FD, Golledge J, Askew CD (2017) Acute inflammatory responses to exercise in patients with abdominal aortic aneurysm. Med Sci Sports Exerc. https:\/\/doi.org\/10.1249\/MSS.0000000000001501","DOI":"10.1249\/MSS.0000000000001501"},{"issue":"4","key":"9716_CR92","doi-asserted-by":"publisher","first-page":"472","DOI":"10.12965\/jer.1735066.533","volume":"13","author":"Y Koh","year":"2017","unstructured":"Koh Y, Park KS (2017) Responses of inflammatory cytokines following moderate intensity walking exercise in overweight or obese individuals. J Exerc Rehabil 13(4):472\u2013476","journal-title":"J Exerc Rehabil"},{"key":"9716_CR93","doi-asserted-by":"publisher","unstructured":"Eder L, Joshi AA, Dey AK, Cook R, Siegel EL, Gladman DD, Mehta NN (2017) TNF-\u03b1 inhibitors are associated with reduced indices of subclinical atherosclerosis in patients with psoriatic disease. Arthritis Rheum. https:\/\/doi.org\/10.1002\/art.40366","DOI":"10.1002\/art.40366"},{"key":"9716_CR94","unstructured":"Atzeni F, Carletto A, Foti R, Sebastiani M, Panetta V, Salaffi F, Bonitta G, Iannone F, Gremese E, Govoni M, Marchesoni A, Favalli EG, Gorla R, Ramonda R, Sarzi-Puttini P, Ferraccioli G, Lapadula G; GISEA group (2017) Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugs. Joint Bone Spine S1297-319X(17)30157-4."},{"issue":"1","key":"9716_CR95","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10741-010-9180-8","volume":"16","author":"P Kleinbongard","year":"2011","unstructured":"Kleinbongard P, Schulz R, Heusch G (2011) TNF\u03b1 in myocardial ischemia\/reperfusion, remodeling and heart failure. Heart Fail Rev 16(1):49\u201369","journal-title":"Heart Fail Rev"},{"issue":"6","key":"9716_CR96","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massagu\u00e9 J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113(6):685\u2013700","journal-title":"Cell"},{"issue":"6","key":"9716_CR97","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.tibs.2015.03.012","volume":"40","author":"MJ Macias","year":"2015","unstructured":"Macias MJ, Martin-Malpartida P, Massagu\u00e9 J (2015) Structural determinants of Smad function in TGF-\u03b2 signaling. Trends Biochem Sci 40(6):296\u2013308","journal-title":"Trends Biochem Sci"},{"issue":"Pt 16","key":"9716_CR98","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1242\/jcs.02554","volume":"118","author":"A Moustakas","year":"2005","unstructured":"Moustakas A, Heldin CH (2005) Non-Smad TGF-beta signals. J Cell Sci 118(Pt 16):3573\u20133584","journal-title":"J Cell Sci"},{"issue":"1","key":"9716_CR99","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/s41598-017-01936-5","volume":"7","author":"W Liu","year":"2017","unstructured":"Liu W, Wang X, Mei Z, Gong J, Huang L, Gao X, Zhao Y, Ma J, Qian L (2017) BNIP3L promotes cardiac fibrosis in cardiac fibroblasts through [Ca2+]i-TGF-\u03b2-Smad2\/3 pathway. Sci Rep 7(1):1906","journal-title":"Sci Rep"},{"issue":"1-2","key":"9716_CR100","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1006\/mgme.2000.3032","volume":"71","author":"PJ Lijnen","year":"2000","unstructured":"Lijnen PJ, Petrov VV, Fagard RH (2000) Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab 71(1-2):418\u2013435","journal-title":"Mol Genet Metab"},{"issue":"7","key":"9716_CR101","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","volume":"107","author":"S Hein","year":"2003","unstructured":"Hein S, Arnon E, Kostin S, Sch\u00f6nburg M, Els\u00e4sser A, Polyakova V, Bauer EP, Kl\u00f6vekorn WP, Schaper J (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107(7):984\u2013991","journal-title":"Circulation"},{"issue":"3","key":"9716_CR102","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/01.CIR.96.3.874","volume":"96","author":"RK Li","year":"1997","unstructured":"Li RK, Li G, Mickle DA, Weisel RD, Merante F, Luss H, Rao V, Christakis GT, Williams WG (1997) Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation 96(3):874\u2013881","journal-title":"Circulation"},{"issue":"5","key":"9716_CR103","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0735-1097(01)01170-6","volume":"37","author":"J Fielitz","year":"2001","unstructured":"Fielitz J, Hein S, Mitrovic V, Pregla R, Zurbr\u00fcgg HR, Warnecke C, Schaper J, Fleck E, Regitz-Zagrosek V (2001) Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. J Am Coll Cardiol 37(5):1443\u20131449","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"9716_CR104","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ejheart.2003.11.014","volume":"6","author":"RP Dai","year":"2004","unstructured":"Dai RP, Dheen ST, He BP, Tay SS (2004) Differential expression of cytokines in the rat heart in response to sustained volume overload. Eur J Heart Fail 6(6):693\u2013703","journal-title":"Eur J Heart Fail"},{"key":"9716_CR105","doi-asserted-by":"crossref","unstructured":"van Wamel AJ, Ruwhof C, van der Valk-Kokshoorn LJ, Schrier PI, van der Laarse A (2002) Stretch-induced paracrine hypertrophic stimuli increase TGF-beta1 expression in cardiomyocytes. Mol Cell Biochem 236(1-2):147-153.","DOI":"10.1023\/A:1016138813353"},{"issue":"6","key":"9716_CR106","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1159\/000479995","volume":"42","author":"J Yuan","year":"2017","unstructured":"Yuan J, Chen H, Ge D, Xu Y, Xu H, Yang Y, Gu M, Zhou Y, Zhu J, Ge T, Chen Q, Gao Y, Wang Y, Li X, Zhao Y (2017) Mir-21 promotes cardiac fibrosis after myocardial infarction via targeting Smad7. Cell Physiol Biochem 42(6):2207\u20132219","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"9716_CR107","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/CIRCRESAHA.117.311045","volume":"121","author":"SA Su","year":"2017","unstructured":"Su SA, Yang D, Wu Y, Xie Y, Zhu W, Cai Z, Shen J, Fu Z, Wang Y, Jia L, Wang Y, Wang JA, Xiang M (2017) EphrinB2 regulates cardiac fibrosis through modulating the interaction of Stat3 and TGF-\u03b2\/Smad3 signaling. Circ Res 121(6):617\u2013627","journal-title":"Circ Res"},{"key":"9716_CR108","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.diabres.2017.08.018","volume":"133","author":"Y Yue","year":"2017","unstructured":"Yue Y, Meng K, Pu Y, Zhang X (2017) Transforming growth factor beta (TGF-\u03b2) mediates cardiac fibrosis and induces diabetic cardiomyopathy. Diabetes Res Clin Pract 133:124\u2013130","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"9716_CR109","first-page":"138","volume":"21","author":"HM Niu","year":"2017","unstructured":"Niu HM, Liu CL (2017) The aberrant expression of Smad6 and TGF-\u03b2 in obesity linked cardiac disease. Eur Rev Med Pharmacol Sci 21(1):138\u2013142","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"9716_CR110","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1172\/JCI44824","volume":"121","author":"N Koitabashi","year":"2011","unstructured":"Koitabashi N, Danner T, Zaiman AL, Pinto YM, Rowell J, Mankowski J, Zhang D, Nakamura T, Takimoto E, Kass DA (2011) Pivotal role of cardiomyocyte TGF-beta signaling in the murine pathological response to sustained pressure overload. J Clin Invest 121:2301\u20132312","journal-title":"J Clin Invest"},{"key":"9716_CR111","doi-asserted-by":"publisher","first-page":"H239","DOI":"10.1152\/ajpheart.00584.2015","volume":"310","author":"MR Zeglinski","year":"2016","unstructured":"Zeglinski MR, Roche P, Hnatowich M, Jassal DS, Wigle JT, Czubryt MP, Dixon IMC (2016) TGF\u03b21 regulates scleraxis expression in primary cardiac myofibroblasts by a Smad-independent mechanism. Am J Physiol Heart Circ Physiol 310:H239\u2013H249","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"9716_CR112","doi-asserted-by":"publisher","first-page":"H75","DOI":"10.1152\/ajpheart.00453.2014","volume":"308","author":"MR Zeglinski","year":"2015","unstructured":"Zeglinski MR, Hnatowich M, Jassal DS, Dixon IMC (2015) SnoN as a novel negative regulator of TGF-\u03b2\/Smad signaling: a target for tailoring organ fibrosis. Am J Physiol Heart Circ Physiol 308(2):H75\u2013H82","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9716_CR113","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/cddis.2015.36","volume":"6","author":"S Ghavami","year":"2015","unstructured":"Ghavami S, Cunnington RH, Gupta S, Yeganeh B, Filomeno KL, Freed DH, Chen S, Klonisch T, Halayko AJ, Ambrose E, Singal R, Dixon IMC (2015) Autophagy is a regulator of TGF-\u03b21-induced fibrogenesis in primary human atrial myofibroblasts. Cell Death Dis 6:1696\u20131706","journal-title":"Cell Death Dis"},{"issue":"11","key":"9716_CR114","doi-asserted-by":"publisher","first-page":"e0188597","DOI":"10.1371\/journal.pone.0188597","volume":"12","author":"HM Yeh","year":"2017","unstructured":"Yeh HM, Lin TT, Yeh CF, Huang HS, Chang SN, Lin JW, Tsai CT, Lai LP, Huang YY, Chu CL (2017) Biomarkers and echocardiography for evaluating the improvement of the ventricular diastolic function after surgical relief of hydronephrosis. PLoS One 12(11):e0188597","journal-title":"PLoS One"},{"issue":"1","key":"9716_CR115","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.advms.2017.10.004","volume":"63","author":"P Rubi\u015b","year":"2017","unstructured":"Rubi\u015b P, Wi\u015bniowska-\u015amia\u0142ek S, Dziewi\u0119cka E, Rudnicka-Sosin L, Kozanecki A, Podolec P (2017) Prognostic value of fibrosis-related markers in dilated cardiomyopathy: a link between osteopontin and cardiovascular events. Adv Med Sci 63(1):160\u2013166","journal-title":"Adv Med Sci"},{"issue":"40","key":"9716_CR116","doi-asserted-by":"publisher","first-page":"16440","DOI":"10.1074\/jbc.M117.788299","volume":"292","author":"T Bansal","year":"2017","unstructured":"Bansal T, Chatterjee E, Singh J, Ray A, Kundu B, Thankamani V, Sengupta S, Sarkar S (2017) Arjunolic acid, a peroxisome proliferator-activated receptor \u03b1 agonist, regresses cardiac fibrosis by inhibiting non-canonical TGF-\u03b2 signaling. J Biol Chem 292(40):16440\u201316462","journal-title":"J Biol Chem"},{"issue":"11","key":"9716_CR117","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/clc.22320","volume":"37","author":"M Hillebrand","year":"2014","unstructured":"Hillebrand M, Millot N, Sheikhzadeh S, Rybczynski M, Gerth S, K\u00f6lbel T, Keyser B, Kutsche K, Robinson PN, Berger J, Mir TS, Zeller T, Blankenberg S, von Kodolitsch Y, Goldmann B (2014) Total serum transforming growth factor-\u03b21 is elevated in the entire spectrum of genetic aortic syndromes. Clin Cardiol 37(11):672\u2013679","journal-title":"Clin Cardiol"},{"issue":"2","key":"9716_CR118","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/dvdy.21677","volume":"238","author":"S Liao","year":"2009","unstructured":"Liao S, Bodmer J, Pietras D, Azhar M, Doetschman T, Schultz Jel J (2009) Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease. Dev Dyn 238(2):249\u2013264","journal-title":"Dev Dyn"},{"key":"9716_CR119","doi-asserted-by":"publisher","first-page":"e97281","DOI":"10.1371\/journal.pone.0097281","volume":"9","author":"JJ Santiago","year":"2014","unstructured":"Santiago JJ, McNaughton LJ, Koleini N, Ma X, Bestvater B, Nickel BE, Fandrich RR, Wigle JT, Freed DH, Arora RC, Kardami E (2014) High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling. PLoS One 9:e97281\u2013e97297","journal-title":"PLoS One"},{"key":"9716_CR120","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/cvr\/cvu066","volume":"103","author":"W Srisakuldee","year":"2014","unstructured":"Srisakuldee W, Makazan Z, Nickel BE, Zhang F, Thliveris JA, Pasumarthi KB, Kardami E (2014) The FGF-2-triggered protection of cardiac subsarcolemmal mitochondria from calcium overload is mitochondrial connexin 43-dependent. Cardiovasc Res 103:72\u201380","journal-title":"Cardiovasc Res"},{"issue":"14","key":"9716_CR121","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117(14):3720\u20133732","journal-title":"Blood"},{"issue":"4","key":"9716_CR122","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","volume":"117","author":"SM Opal","year":"2000","unstructured":"Opal SM, De Palo VA (2000) Anti-inflammatory cytokines. Chest 117(4):1162\u20131172","journal-title":"Chest"},{"issue":"5","key":"9716_CR123","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0192-0561(93)90075-A","volume":"15","author":"D Weisensee","year":"1993","unstructured":"Weisensee D, Bereiter-Hahn J, Schoeppe W, L\u00f6w-Friedrich I (1993) Effects of cytokines on the contractility of cultured cardiac myocytes. Int J Immunopharmacol 15(5):581\u2013587","journal-title":"Int J Immunopharmacol"},{"issue":"8","key":"9716_CR124","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/cvr\/27.8.1486","volume":"27","author":"HG Evans","year":"1993","unstructured":"Evans HG, Lewis MJ, Shah AM (1993) Interleukin-1 beta modulates myocardial contraction via dexamethasone sensitive production of nitric oxide. Cardiovasc Res 27(8):1486\u20131490","journal-title":"Cardiovasc Res"},{"issue":"2","key":"9716_CR125","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/A:1011428824771","volume":"6","author":"CS Long","year":"2001","unstructured":"Long CS (2001) The role of interleukin-1 in the failing heart. Heart Fail Rev 6(2):81\u201394","journal-title":"Heart Fail Rev"},{"key":"9716_CR126","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/BF00408670","volume":"163-164","author":"K Werdan","year":"1996","unstructured":"Werdan K, M\u00fcller-Werdan U (1996) Elucidating molecular mechanisms of septic cardiomyopathy\u2014the cardiomyocyte model. Mol Cell Biochem 163-164:291\u2013303","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"9716_CR127","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1073\/pnas.041611398","volume":"98","author":"BJ Pomerantz","year":"2001","unstructured":"Pomerantz BJ, Reznikov LL, Harken AH, Dinarello CA (2001) Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta. Proc Natl Acad Sci U S A 98(5):2871\u20132876","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"9716_CR128","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.athoracsur.2008.01.043","volume":"85","author":"J Cha","year":"2008","unstructured":"Cha J, Wang Z, Ao L, Zou N, Dinarello CA, Banerjee A, Fullerton DA, Meng X (2008) Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia. Ann Thorac Surg 85(5):1678\u20131685","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"9716_CR129","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","volume":"123","author":"M Kawaguchi","year":"2011","unstructured":"Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J, Hongo M, Noda T, Nakayama J, Sagara J, Taniguchi S, Ikeda U (2011) Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury. Circulation 123(6):594\u2013604","journal-title":"Circulation"},{"key":"9716_CR130","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.intimp.2016.11.018","volume":"43","author":"Z Yu","year":"2017","unstructured":"Yu Z, Wang S, Zhang X, Li Y, Zhao Q, Liu T (2017) Pterostilbene protects against myocardial ischemia\/reperfusion injury via suppressing oxidative\/nitrative stress and inflammatory response. Int Immunopharmacol 43:7\u201315","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"9716_CR131","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10753-014-9959-1","volume":"38","author":"ZG Zhao","year":"2015","unstructured":"Zhao ZG, Tang ZZ, Zhang WK, Li JG (2015) Protective effects of embelin on myocardial ischemia-reperfusion injury following cardiac arrest in a rabbit model. Inflammation 38(2):527\u2013533","journal-title":"Inflammation"},{"issue":"2","key":"9716_CR132","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s13105-014-0320-9","volume":"70","author":"H Ebrahimi","year":"2014","unstructured":"Ebrahimi H, Badalzadeh R, Mohammadi M, Yousefi B (2014) Diosgenin attenuates inflammatory response induced by myocardial reperfusion injury: role of mitochondrial ATP-sensitive potassium channels. J Physiol Biochem 70(2):425\u2013432","journal-title":"J Physiol Biochem"},{"issue":"8","key":"9716_CR133","doi-asserted-by":"publisher","first-page":"e0135435","DOI":"10.1371\/journal.pone.0135435","volume":"10","author":"Y Deng","year":"2015","unstructured":"Deng Y, Yang M, Xu F, Zhang Q, Zhao Q, Yu H, Li D, Zhang G, Lu A, Cho K, Teng F, Wu P, Wang L, Wu W, Liu X, Guo DA, Jiang B (2015) Combined salvianolic acid B and ginsenoside Rg1 exerts cardioprotection against ischemia\/reperfusion injury in rats. PLoS One 10(8):e0135435","journal-title":"PLoS One"},{"issue":"6","key":"9716_CR134","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10557-016-6701-2","volume":"30","author":"Y Birnbaum","year":"2016","unstructured":"Birnbaum Y, Birnbaum GD, Birnbaum I, Nylander S, Ye Y (2016) Ticagrelor and rosuvastatin have additive cardioprotective effects via adenosine. Cardiovasc Drugs Ther 30(6):539\u2013550","journal-title":"Cardiovasc Drugs Ther"},{"key":"9716_CR135","doi-asserted-by":"publisher","first-page":"815094","DOI":"10.1155\/2013\/815094","volume":"2013","author":"NR Hadi","year":"2013","unstructured":"Hadi NR, Al-Amran F, Yousif M, Zamil ST (2013) Antiapoptotic effect of simvastatin ameliorates myocardial ischemia\/reperfusion injury. ISRN Pharmacol 2013:815094","journal-title":"ISRN Pharmacol"},{"issue":"9","key":"9716_CR136","doi-asserted-by":"publisher","first-page":"e45243","DOI":"10.1371\/journal.pone.0045243","volume":"7","author":"A Varma","year":"2012","unstructured":"Varma A, Das A, Hoke NN, Durrant DE, Salloum FN, Kukreja RC (2012) Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice. PLoS One 7(9):e45243","journal-title":"PLoS One"},{"key":"9716_CR137","doi-asserted-by":"crossref","unstructured":"Grothusen C, Hagemann A, Attmann T, Braesen J, Broch O, Cremer J, Schoettler J (2012) Impact of an interleukin-1 receptor antagonist and erythropoietin on experimental myocardial ischemia\/reperfusion injury. Sci World J:737585.","DOI":"10.1100\/2012\/737585"},{"issue":"3","key":"9716_CR138","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10557-012-6389-x","volume":"26","author":"S Toldo","year":"2012","unstructured":"Toldo S, Schatz AM, Mezzaroma E, Chawla R, Stallard TW, Stallard WC, Jahangiri A, Van Tassell BW, Abbate A (2012) Recombinant human interleukin-1 receptor antagonist provides cardioprotection during myocardial ischemia reperfusion in the mouse. Cardiovasc Drugs Ther 26(3):273\u2013276","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"9716_CR139","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1536\/ihj.50.235","volume":"50","author":"S Ohki","year":"2009","unstructured":"Ohki S, Oshima K, Tsutsumi H, Koike N, Matsumoto K, Takeyoshi I (2009) The suppression of proinflammatory cytokines improves heart function from non-heart-beating donors following transplantation in a canine model. Int Heart J 50(2):235\u2013245","journal-title":"Int Heart J"},{"key":"9716_CR140","doi-asserted-by":"publisher","first-page":"I308","DOI":"10.1161\/hc37t1.094871","volume":"104","author":"K Suzuki","year":"2001","unstructured":"Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, Yacoub MH (2001) Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 104:I308\u2013I313","journal-title":"Circulation"},{"issue":"3","key":"9716_CR141","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/FJC.0000000000000452","volume":"69","author":"AG Mauro","year":"2017","unstructured":"Mauro AG, Mezzaroma E, Torrado J, Kundur P, Joshi P, Stroud K, Quaini F, Lagrasta CA, Abbate A, Toldo S (2017) Reduction of myocardial ischemia-reperfusion injury by inhibiting interleukin-1 alpha. J Cardiovasc Pharmacol 69(3):156\u2013160","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"9716_CR142","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jcmm.12915","volume":"21","author":"Y Wang","year":"2017","unstructured":"Wang Y, Yan X, Mi S, Li Z, Wang Y, Zhu H, Sun X, Zhao B, Zhao C, Zou Y, Hu K, Ding X, Sun A, Ge J (2017) Naoxintong attenuates ischaemia\/reperfusion injury through inhibiting NLRP3 inflammasome activation. J Cell Mol Med 21(1):4\u201312","journal-title":"J Cell Mol Med"},{"issue":"2","key":"9716_CR143","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1536\/ihj.16-241","volume":"58","author":"J Huang","year":"2017","unstructured":"Huang J, Li Y, Zhang J, Liu Y, Lu Q (2017) The growth hormone secretagogue hexarelin protects rat cardiomyocytes from in vivo ischemia\/reperfusion injury through interleukin-1 signaling pathway. Int Heart J 58(2):257\u2013263","journal-title":"Int Heart J"},{"issue":"4","key":"9716_CR144","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/1050-1738(92)90022-K","volume":"2","author":"LG Lange","year":"1992","unstructured":"Lange LG, Schreiner GF (1992) Immune cytokines and cardiac disease. Trends Cardiovasc Med 2(4):145\u2013151","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"9716_CR145","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1006\/jmcc.1997.0592","volume":"30","author":"SE Francis","year":"1998","unstructured":"Francis SE, Holden H, Holt CM, Duff GW (1998) Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol 30(2):215\u2013223","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"9716_CR146","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1515\/cclm-2012-0600","volume":"51","author":"B Luo","year":"2013","unstructured":"Luo B, Wang F, Li B, Dong Z, Liu X, Zhang C, An F (2013) Association of nucleotide-binding oligomerization domain-like receptor 3 inflammasome and adverse clinical outcomes in patients with idiopathic dilated cardiomyopathy. Clin Chem Lab Med 51(7):1521\u20131528","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"9716_CR147","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1136\/jmg.31.10.766","volume":"31","author":"M Krajinovic","year":"1994","unstructured":"Krajinovic M, Mestroni L, Severini GM, Pinamonti B, Camerini F, Falaschi A, Giacca M (1994) Absence of linkage between idiopathic dilated cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree. J Med Genet 31(10):766\u2013771","journal-title":"J Med Genet"},{"issue":"9","key":"9716_CR148","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0002-9149(97)89206-5","volume":"77","author":"MA Munger","year":"1996","unstructured":"Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM (1996) Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77(9):723\u2013727","journal-title":"Am J Cardiol"},{"issue":"6","key":"9716_CR149","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1136\/hrt.72.6.561","volume":"72","author":"A Matsumori","year":"1994","unstructured":"Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S (1994) Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 72(6):561\u2013566","journal-title":"Br Heart J"},{"issue":"5","key":"9716_CR150","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF00199511","volume":"427","author":"M Satoh","year":"1996","unstructured":"Satoh M, Tamura G, Segawa I, Tashiro A, Hiramori K, Satodate R (1996) Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy. Virchows Arch 427(5):503\u2013509","journal-title":"Virchows Arch"},{"issue":"3","key":"9716_CR151","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1084\/jem.20021788","volume":"197","author":"U Eriksson","year":"2003","unstructured":"Eriksson U, Kurrer MO, Sonderegger I, Iezzi G, Tafuri A, Hunziker L, Suzuki S, Bachmaier K, Bingisser RM, Penninger JM, Kopf M (2003) Activation of dendritic cells through the interleukin-1 receptor 1 is critical for the induction of autoimmune myocarditis. J Exp Med 197(3):323\u2013331","journal-title":"J Exp Med"},{"issue":"9","key":"9716_CR152","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1161\/CIRCRESAHA.109.199802","volume":"105","author":"P Blyszczuk","year":"2009","unstructured":"Blyszczuk P, Kania G, Dieterle T, Marty RR, Valaperti A, Berthonneche C, Pedrazzini T, Berger CT, Dirnhofer S, Matter CM, Penninger JM, L\u00fcscher TF, Eriksson U (2009) Myeloid differentiation factor-88\/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circ Res 105(9):912\u2013920","journal-title":"Circ Res"},{"issue":"6","key":"9716_CR153","doi-asserted-by":"publisher","first-page":"H922","DOI":"10.1152\/ajpheart.00076.2014","volume":"307","author":"HY Pan","year":"2014","unstructured":"Pan HY, Sun HM, Xue LJ, Pan M, Wang YP, Kido H, Zhu JH (2014) Ectopic trypsin in the myocardium promotes dilated cardiomyopathy after influenza A virus infection. Am J Physiol Heart Circ Physiol 307(6):H922\u2013H932","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"9716_CR154","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1620\/tjem.227.225","volume":"227","author":"ZC Song","year":"2012","unstructured":"Song ZC, Wang ZS, Bai JH, Li Z, Hu J (2012) Emodin, a naturally occurring anthraquinone, ameliorates experimental autoimmune myocarditis in rats. Tohoku J Exp Med 227(3):225\u2013230","journal-title":"Tohoku J Exp Med"},{"issue":"Suppl 2","key":"9716_CR155","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1046\/j.1540-8191.18.s2.8.x","volume":"18","author":"A Ukimura","year":"2003","unstructured":"Ukimura A, Terasaki F, Fujioka S, Deguchi H, Kitaura Y, Isomura T, Suma H (2003) Quantitative analysis of cytokine mRNA expression in hearts from patients with nonischemic dilated cardiomyopathy (DCM). J Card Surg 18(Suppl 2):S101\u2013S108","journal-title":"J Card Surg"},{"key":"9716_CR156","doi-asserted-by":"crossref","unstructured":"Aleksova A, Beltrami AP, Carriere C, Barbati G, Lesizza P, Perrieri-Montanino M, Isola M, Gentile P, Salvioni E, Not T, Agostoni P, G1 S (2017) Interleukin-1\u03b2 levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy. Oncotarget 8(15):25131\u201325140","DOI":"10.18632\/oncotarget.15349"},{"issue":"7","key":"9716_CR157","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/1097-0142(19901001)66:7<1513::AID-CNCR2820660713>3.0.CO;2-X","volume":"66","author":"AH Kragel","year":"1990","unstructured":"Kragel AH, Travis WD, Steis RG, Rosenberg SA, Roberts WC (1990) Myocarditis or acute myocardial infarction associated with interleukin-2 therapy for cancer. Cancer 66(7):1513\u20131516","journal-title":"Cancer"},{"issue":"3","key":"9716_CR158","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1081\/CNV-200029070","volume":"22","author":"RM Eisner","year":"2004","unstructured":"Eisner RM, Husain A, Clark JI (2004) Case report and brief review: IL-2-induced myocarditis. Cancer Investig 22(3):401\u2013404","journal-title":"Cancer Investig"},{"issue":"2","key":"9716_CR159","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7150\/ijms.17119","volume":"14","author":"W Yan","year":"2017","unstructured":"Yan W, Song Y, Zhou L, Jiang J, Yang F, Duan Q, Che L, Shen Y, Song H, Wang L (2017) Immune cell repertoire and their mediators in patients with acute myocardial infarction or stable angina pectoris. Int J Med Sci 14(2):181\u2013190","journal-title":"Int J Med Sci"},{"issue":"3","key":"9716_CR160","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1136\/hrt.75.3.287","volume":"75","author":"JB Marriott","year":"1996","unstructured":"Marriott JB, Goldman JH, Keeling PJ, Baig MK, Dalgleish AG, McKenna WJ (1996) Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. Heart 75(3):287\u2013290","journal-title":"Heart"},{"issue":"1","key":"9716_CR161","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10875-006-7585-x","volume":"26","author":"F Kuethe","year":"2006","unstructured":"Kuethe F, Braun RK, Foerster M, Schlenker Y, Sigusch HH, Kroegel C, Figulla HR (2006) Immunopathogenesis of dilated cardiomyopathy. Evidence for the role of TH2-type CD4+T lymphocytes and association with myocardial HLA-DR expression. J Clin Immunol 26(1):33\u201339","journal-title":"J Clin Immunol"},{"issue":"2","key":"9716_CR162","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1124\/jpet.103.061135","volume":"309","author":"CM Cao","year":"2004","unstructured":"Cao CM, Xia Q, Tu J, Chen M, Wu S, Wong TM (2004) Cardioprotection of interleukin-2 is mediated via kappa-opioid receptors. J Pharmacol Exp Ther 309(2):560\u2013567","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"9716_CR163","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cyto.2011.09.023","volume":"56","author":"M Bouchentouf","year":"2011","unstructured":"Bouchentouf M, Williams P, Forner KA, Cuerquis J, Michaud V, Paradis P, Schiffrin EL, Galipeau J (2011) Interleukin-2 enhances angiogenesis and preserves cardiac function following myocardial infarction. Cytokine 56(3):732\u2013738","journal-title":"Cytokine"},{"issue":"6","key":"9716_CR164","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1309\/Q3E6KF0QD3U3YL6T","volume":"125","author":"TB Martins","year":"2006","unstructured":"Martins TB, Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Roberts WL, Carlquist JF (2006) Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay. Am J Clin Pathol 125(6):906\u2013913","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"9716_CR165","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00380-010-0076-2","volume":"26","author":"J Szkodzinski","year":"2011","unstructured":"Szkodzinski J, Hudzik B, Osuch M, Romanowski W, Szygula-Jurkiewicz B, Polonski L, Zubelewicz-Szkodzinska B (2011) Serum concentrations of interleukin-4 and interferon-gamma in relation to severe left ventricular dysfunction in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart Vessel 26(4):399\u2013407","journal-title":"Heart Vessel"},{"issue":"4","key":"9716_CR166","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1084\/jem.20161702","volume":"214","author":"NL Diny","year":"2017","unstructured":"Diny NL, Baldeviano GC, Talor MV, Barin JG, Ong S, Bedja D, Hays AG, Gilotra NA, Coppens I, Rose NR, \u010cih\u00e1kov\u00e1 D (2017) Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy. J Exp Med 214(4):943\u2013957","journal-title":"J Exp Med"},{"issue":"7","key":"9716_CR167","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1157\/13108284","volume":"60","author":"E Rosell\u00f3-Llet\u00ed","year":"2007","unstructured":"Rosell\u00f3-Llet\u00ed E, Rivera M, Bertomeu V, Cort\u00e9s R, Jord\u00e1n A, Gonz\u00e1lez-Molina A (2007) Interleukin-4 and cardiac fibrosis in patients with heart failure. Rev Esp Cardiol 60(7):777\u2013780","journal-title":"Rev Esp Cardiol"},{"issue":"3","key":"9716_CR168","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1161\/HYPERTENSIONAHA.115.05627","volume":"66","author":"H Peng","year":"2015","unstructured":"Peng H, Sarwar Z, Yang XP, Peterson EL, Xu J, Janic B, Rhaleb N, Carretero OA, Rhaleb NE (2015) Profibrotic role for interleukin-4 in cardiac remodeling and dysfunction. Hypertension 66(3):582\u2013589","journal-title":"Hypertension"},{"issue":"6","key":"9716_CR169","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1172\/JCI85782","volume":"126","author":"M Shiraishi","year":"2016","unstructured":"Shiraishi M, Shintani Y, Shintani Y, Ishida H, Saba R, Yamaguchi A, Adachi H, Yashiro K, Suzuki K (2016) Alternatively activated macrophages determine repair of the infarcted adult murine heart. J Clin Invest 126(6):2151\u20136216","journal-title":"J Clin Invest"},{"issue":"1","key":"9716_CR170","doi-asserted-by":"publisher","first-page":"6877","DOI":"10.1038\/s41598-017-07328-z","volume":"7","author":"Y Shintani","year":"2017","unstructured":"Shintani Y, Ito T, Fields L, Shiraishi M, Ichihara Y, Sato N, Podaru M, Kainuma S, Tanaka H, Suzuki K (2017) IL-4 as a repurposed biological drug for myocardial infarction through augmentation of reparative cardiac macrophages: proof-of-concept data in mice. Sci Rep 7(1):6877","journal-title":"Sci Rep"},{"key":"9716_CR171","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.molimm.2016.11.006","volume":"81","author":"F Wan","year":"2017","unstructured":"Wan F, Yan K, Xu D, Qian Q, Liu H, Li M, Xu W (2017) V\u03b31+\u03b3\u03b4T, early cardiac infiltrated innate population dominantly producing IL-4, protect mice against CVB3 myocarditis by modulating IFN\u03b3+ T response. Mol Immunol 81:16\u201325","journal-title":"Mol Immunol"},{"key":"9716_CR172","doi-asserted-by":"publisher","first-page":"22613","DOI":"10.1038\/srep22613","volume":"6","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhang M, Li X, Tang Z, Wang X, Zhong M, Suo Q, Zhang Y, Lv K (2016) Silencing micro RNA-155 attenuates cardiac injury and dysfunction in viral myocarditis via promotion of M2 phenotype polarization of macrophages. Sci Rep 6:22613","journal-title":"Sci Rep"},{"issue":"3","key":"9716_CR173","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijcard.2004.03.067","volume":"101","author":"W Kosmala","year":"2005","unstructured":"Kosmala W, Przewlocka-Kosmala M, Mazurek W (2005) Proinflammatory cytokines and myocardial viability in patients after acute myocardial infarction. Int J Cardiol 101(3):449\u2013456","journal-title":"Int J Cardiol"},{"issue":"3","key":"9716_CR174","doi-asserted-by":"publisher","first-page":"455","DOI":"10.12740\/PP\/33179","volume":"49","author":"A Wilkowska","year":"2015","unstructured":"Wilkowska A, Piku\u0142a M, Rynkiewicz A, Wdowczyk-Szulc J, Trzonkowski P, Landowski J (2015) Increased plasma pro-inflammatory cytokine concentrations after myocardial infarction and the presence of depression during next 6-months. Psychiatr Pol 49(3):455\u2013464","journal-title":"Psychiatr Pol"},{"issue":"3","key":"9716_CR175","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1590\/1414-431X20132999","volume":"47","author":"XJ Zhao","year":"2014","unstructured":"Zhao XJ, Liu XL, He GX, Xu HP (2014) Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion. Braz J Med Biol Res 47(3):245\u2013251","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"9716_CR176","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/01.CIR.99.3.427","volume":"99","author":"B Chandrasekar","year":"1999","unstructured":"Chandrasekar B, Mitchell DH, Colston JT, Freeman GL (1999) Regulation of CCAAT\/Enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia\/reperfusion. Circulation 99(3):427\u2013433","journal-title":"Circulation"},{"issue":"3","key":"9716_CR177","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.cyto.2013.03.020","volume":"62","author":"DR Anderson","year":"2013","unstructured":"Anderson DR, Poterucha JT, Mikuls TR, Duryee MJ, Garvin RP, Klassen LW, Shurmur SW, Thiele GM (2013) IL-6 and its receptors in coronary artery disease and acute myocardial infarction. Cytokine 62(3):395\u2013400","journal-title":"Cytokine"},{"issue":"4","key":"9716_CR178","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.cellsig.2012.12.008","volume":"25","author":"A Fahmi","year":"2013","unstructured":"Fahmi A, Smart N, Punn A, Jabr R, Marber M, Heads R (2013) p42\/p44-MAPK and PI3K are sufficient for IL-6 family cytokines\/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK\/STAT activation. Cell Signal 25(4):898\u2013909","journal-title":"Cell Signal"},{"issue":"8","key":"9716_CR179","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/BF03343766","volume":"23","author":"M Nishino","year":"2000","unstructured":"Nishino M, Kimura T, Kanda T, Kotajima N, Yoshida A, Kuwabara A, Tamama K, Fukumura Y, Kobayashi I (2000) Circulating interleukin-6 significantly correlates to thyroid hormone in acute myocardial infarction but not in chronic heart failure. J Endocrinol Investig 23(8):509\u2013514","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"9716_CR180","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00392-007-0626-5","volume":"97","author":"M Debrunner","year":"2008","unstructured":"Debrunner M, Schuiki E, Minder E, Straumann E, Naegeli B, Mury R, Bertel O, Frielingsdorf J (2008) Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol 97(5):298\u2013305","journal-title":"Clin Res Cardiol"},{"issue":"10","key":"9716_CR181","doi-asserted-by":"publisher","first-page":"e005637","DOI":"10.1161\/JAHA.117.005637","volume":"6","author":"CL Fanola","year":"2017","unstructured":"Fanola CL, Morrow DA, Cannon CP, Jarolim P, Lukas MA, Bode C, Hochman JS, Goodrich EL, Braunwald E, O'Donoghue ML (2017) Interleukin-6 and the risk of adverse outcomes in patients after an acute coronary syndrome: observations from the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) trial. J Am Heart Assoc 6(10):e005637","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"9716_CR182","doi-asserted-by":"publisher","first-page":"e005077","DOI":"10.1161\/JAHA.116.005077","volume":"6","author":"C Held","year":"2017","unstructured":"Held C, White HD, Stewart RAH, Budaj A, Cannon CP, Hochman JS, Koenig W, Siegbahn A, Steg PG, Soffer J, Weaver WD, \u00d6stlund O, Wallentin L, STABILITY Investigators (2017) Inflammatory biomarkers interleukin-6 and C-reactive protein and outcomes in stable coronary heart disease: experiences from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) trial. J Am Heart Assoc 6(10):e005077","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"9716_CR183","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.7150\/thno.19435","volume":"7","author":"AE Mayfield","year":"2017","unstructured":"Mayfield AE, Kanda P, Nantsios A, Parent S, Mount S, Dixit S, Ye B, Seymour R, Stewart DJ, Davis DR (2017) Interleukin-6 mediates post-infarct repair by cardiac explant-derived stem cells. Theranostics 7(19):4850\u20134861 eCollection 2017","journal-title":"Theranostics"},{"issue":"6","key":"9716_CR184","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1089\/107999003766628179","volume":"23","author":"JT Parissis","year":"2003","unstructured":"Parissis JT, Adamopoulos SN, Venetsanou KF, Karas SM, Kremastinos DT (2003) Elevated plasma amylase levels in advanced chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy: correlation with circulating interleukin-6 activity. J Interf Cytokine Res 23(6):329\u2013333","journal-title":"J Interf Cytokine Res"},{"issue":"2","key":"9716_CR185","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.amjcard.2004.03.078","volume":"94","author":"M H\u00f6gye","year":"2004","unstructured":"H\u00f6gye M, M\u00e1ndi Y, Csan\u00e1dy M, Sepp R, Buz\u00e1s K (2004) Comparison of circulating levels of interleukin-6 and tumor necrosis factor-alpha in hypertrophic cardiomyopathy and in idiopathic dilated cardiomyopathy. Am J Cardiol 94(2):249\u2013251","journal-title":"Am J Cardiol"},{"issue":"5","key":"9716_CR186","doi-asserted-by":"publisher","first-page":"407","DOI":"10.5144\/0256-4947.2014.407","volume":"34","author":"A Liaquat","year":"2014","unstructured":"Liaquat A, Asifa GZ, Zeenat A, Javed Q (2014) Polymorphisms of tumor necrosis factor-alpha and interleukin-6 gene and C-reactive protein profiles in patients with idiopathic dilated cardiomyopathy. Ann Saudi Med 34(5):407\u2013414","journal-title":"Ann Saudi Med"},{"issue":"2","key":"9716_CR187","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1515\/cclm-2014-0502","volume":"53","author":"A Liaquat","year":"2015","unstructured":"Liaquat A, Shauket U, Ahmad W, Javed Q (2015) The tumor necrosis factor-\u03b1 -238G\/A and IL-6 -572G\/C gene polymorphisms and the risk of idiopathic dilated cardiomyopathy: a meta-analysis of 25 studies including 9493 cases and 13,971 controls. Clin Chem Lab Med 53(2):307\u2013318","journal-title":"Clin Chem Lab Med"},{"key":"9716_CR188","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1126\/science.181845","volume":"193","author":"DA Morgan","year":"1976","unstructured":"Morgan DA, Ruscetti FW, Gallo R (1976) Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193:1007\u20131008","journal-title":"Science"},{"issue":"5","key":"9716_CR189","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cytogfr.2006.07.003","volume":"17","author":"HP Kim","year":"2006","unstructured":"Kim HP, Imbert J, Leonard WJ (2006) Both integrated and differential regulation of components of the IL-2\/IL-2 receptor system. Cytokine Growth Factor Rev 17(5):349\u2013366","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"9716_CR190","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","volume":"23","author":"W Liao","year":"2011","unstructured":"Liao W, Lin JX, Leonard WJ (2011) IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 23(5):598\u2013604","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"9716_CR191","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/00002371-199603000-00006","volume":"19","author":"G Citterio","year":"1996","unstructured":"Citterio G, Fragasso G, Rossetti E, Di Lucca G, Bucci E, Foppoli M, Guerrieri R, Matteucci P, Polastri D, Scaglietti U, Tresoldi M, Chierchia SL, Rugarli C (1996) Isolated left ventricular filling abnormalities may predict interleukin-2-induced cardiovascular toxicity. J Immunother Emphasis Tumor Immunol 19(2):134\u2013141","journal-title":"J Immunother Emphasis Tumor Immunol"},{"issue":"2","key":"9716_CR192","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0021-9150(99)00104-5","volume":"145","author":"A Mazzone","year":"1999","unstructured":"Mazzone A, De Servi S, Vezzoli M, Fossati G, Mazzucchelli I, Gritti D, Ottini E, Mussini A, Specchia G (1999) Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 145(2):369\u2013374","journal-title":"Atherosclerosis"},{"issue":"3","key":"9716_CR193","first-page":"678","volume":"37","author":"JC Quinaglia e Silva","year":"2014","unstructured":"Quinaglia e Silva JC, Coelho-Filho OR, Andrade JM, Quinaglia T, Modolo RG, Almeida BO, van der Geest RJ, Jerosch-Herold M, Coelho OR, Sposito AC, Brasilia Heart Study Group (2014) Peri-infarct zone characterized by cardiac magnetic resonance imaging is directly associated with the inflammatory activity during acute phase myocardial infarction. Inflammation 37(3):678\u2013685","journal-title":"Inflammation"},{"issue":"7","key":"9716_CR194","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/MCA.0000000000000282","volume":"26","author":"SH Li","year":"2015","unstructured":"Li SH, Chen WJ, Yan M, Shu YW, Liao YH (2015) Expression of coinhibitory PD-L1 on CD4+CD25+FOXP3+ regulatory T cells is elevated in patients with acute coronary syndrome. Coron Artery Dis 26(7):598\u2013603","journal-title":"Coron Artery Dis"},{"issue":"1","key":"9716_CR195","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0021-9150(97)00107-X","volume":"133","author":"T Nabata","year":"1997","unstructured":"Nabata T, Fukuo K, Morimoto S, Kitano S, Momose N, Hirotani A, Nakahashi T, Nishibe A, Hata S, Niinobu T, Suhara T, Shimizu M, Ohkuma H, Sakurai S, Nishimaki H, Ogihara T (1997) Interleukin-2 modulates the responsiveness to angiotensin II in cultured vascular smooth muscle cells. Atherosclerosis 133(1):23\u201330","journal-title":"Atherosclerosis"},{"issue":"1","key":"9716_CR196","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/01.CIR.91.1.20","volume":"91","author":"A Blum","year":"1995","unstructured":"Blum A, Sclarovsky S, Shohat B (1995) T lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty. Circulation 91(1):20\u201322","journal-title":"Circulation"},{"issue":"1","key":"9716_CR197","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1388-9842(02)00117-4","volume":"5","author":"A Abbate","year":"2003","unstructured":"Abbate A, Vecile E, Fiotti N, Giansante C, Guarnieri G, Di Sciascio G, Dobrina A (2003) Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction. Eur J Heart Fail 5(1):23\u201325","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"9716_CR198","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/01.CIR.91.3.631","volume":"91","author":"CJ Limas","year":"1995","unstructured":"Limas CJ, Goldenberg IF, Limas C (1995) Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies. Circulation 91(3):631\u2013634","journal-title":"Circulation"},{"issue":"2","key":"9716_CR199","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1388-9842(00)00148-3","volume":"3","author":"AL Caforio","year":"2001","unstructured":"Caforio AL, Goldman JH, Baig MK, Mahon NJ, Haven AJ, Souberbielle BE, Holt DW, Dalgleish AG, McKenna WJ (2001) Elevated serum levels of soluble interleukin-2 receptor, neopterin and beta-2-microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis. Eur J Heart Fail 3(2):155\u2013163","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"9716_CR200","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.intimp.2009.11.001","volume":"10","author":"M Koch","year":"2010","unstructured":"Koch M, Savvatis K, Scheeler M, Dhayat S, Bonaventura K, Pohl T, Riad A, Bulfone-Paus S, Schultheiss HP, Tsch\u00f6pe C (2010) Immunosuppression with an interleukin-2 fusion protein leads to improved LV function in experimental ischemic cardiomyopathy. Int Immunopharmacol 10(2):207\u2013212","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"9716_CR201","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/CIRCULATIONAHA.116.023365","volume":"136","author":"N Borg","year":"2017","unstructured":"Borg N, Alter C, G\u00f6rldt N, Jacoby C, Ding Z, Steckel B, Quast C, B\u00f6nner F, Friebe D, Temme S, Fl\u00f6gel U, Schrader J (2017) CD73 on T cells orchestrates cardiac wound healing after myocardial infarction by purinergic metabolic reprogramming. Circulation 136(3):297\u2013313","journal-title":"Circulation"},{"key":"9716_CR202","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1146\/annurev.immunol.17.1.701","volume":"17","author":"K Nelms","year":"1999","unstructured":"Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE (1999) The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17:701\u2013738","journal-title":"Annu Rev Immunol"},{"key":"9716_CR203","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.0105-2896.2004.00209.x","volume":"202","author":"KA Mowen","year":"2004","unstructured":"Mowen KA, Glimcher LH (2004) Signaling pathways in Th2 development. Immunol Rev 202:203\u2013222","journal-title":"Immunol Rev"},{"issue":"4","key":"9716_CR204","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1189\/jlb.0412214","volume":"92","author":"IG Luzina","year":"2012","unstructured":"Luzina IG, Keegan AD, Heller NM, Rook GAW, Shea-Donohue T, Atamas SP (2012) Regulation of inflammation by interleukin-4: a review of \u201calternatives\u201d. J Leukoc Biol 92(4):753\u2013764","journal-title":"J Leukoc Biol"},{"key":"9716_CR205","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1073\/pnas.86.10.3803","volume":"86","author":"PH Hart","year":"1989","unstructured":"Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA (1989) Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci U S A 86:3803\u20133807","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9716_CR206","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.4049\/jimmunol.168.5.2456","volume":"168","author":"J Major","year":"2002","unstructured":"Major J, Fletcher JE, Hamilton TA (2002) IL-4 pretreatment selectively enhances cytokine and chemokine production in lipopolysaccharide-stimulated mouse peritoneal macrophages. J Immunol 168:2456\u20132463","journal-title":"J Immunol"},{"issue":"10","key":"9716_CR207","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1111\/j.1538-7836.2008.03096.x","volume":"6","author":"E Paffen","year":"2008","unstructured":"Paffen E, Medina P, de Visser MC, van Wijngaarden A, Zorio E, Estell\u00e9s A, Rosendaal FR, Espa\u00f1a F, Bertina RM, Doggen CJ (2008) The -589C>T polymorphism in the interleukin-4 gene (IL-4) is associated with a reduced risk of myocardial infarction in young individuals. J Thromb Haemost 6(10):1633\u20131638","journal-title":"J Thromb Haemost"},{"issue":"3","key":"9716_CR208","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s10875-005-4088-0","volume":"25","author":"X Cheng","year":"2005","unstructured":"Cheng X, Liao YH, Ge H, Li B, Zhang J, Yuan J, Wang M, Liu Y, Guo Z, Chen J, Zhang J, Zhang L (2005) TH1\/TH2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. J Clin Immunol 25(3):246\u2013253","journal-title":"J Clin Immunol"},{"issue":"5","key":"9716_CR209","doi-asserted-by":"publisher","first-page":"H3014","DOI":"10.1152\/ajpheart.00797.2007","volume":"293","author":"C Moro","year":"2007","unstructured":"Moro C, Jouan MG, Rakotovao A, Toufektsian MC, Ormezzano O, Nagy N, Tosaki A, de Leiris J, Boucher F (2007) Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodeling. Am J Physiol Heart Circ Physiol 293(5):H3014\u2013H3019","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"9716_CR210","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1590\/S0100-879X2010007500014","volume":"43","author":"S Lachtermacher","year":"2010","unstructured":"Lachtermacher S, Esporcatte BL, Montalv\u00e3o F, Costa PC, Rodrigues DC, Belem L, Rabischoffisky A, Faria Neto HC, Vasconcellos R, Iacobas S, Iacobas DA, Dohmann HF, Spray DC, Goldenberg RC, Campos-de-Carvalho AC (2010) Cardiac gene expression and systemic cytokine profile are complementary in a murine model of post-ischemic heart failure. Braz J Med Biol Res 43(4):377\u2013389","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"9716_CR211","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s10753-015-0294-y","volume":"39","author":"S Zhang","year":"2016","unstructured":"Zhang S, Liu X, Sun C, Yang J, Wang L, Liu J, Gong L, Jing Y (2016) Apigenin attenuates experimental autoimmune myocarditis by modulating Th1\/Th2 cytokine balance in mice. Inflammation 39(2):678\u2013686","journal-title":"Inflammation"},{"issue":"10","key":"9716_CR212","doi-asserted-by":"publisher","first-page":"e108984","DOI":"10.1371\/journal.pone.0108984","volume":"9","author":"AS Bossa","year":"2014","unstructured":"Bossa AS, Salemi VM, Ribeiro SP, Rosa DS, Ferreira LR, Ferreira SC, Nishiya AS, Mady C, Kalil J, Cunha-Neto E (2014) Plasma cytokine profile in tropical endomyocardial fibrosis: predominance of TNF-a, IL-4 and IL-10. PLoS One 9(10):e108984","journal-title":"PLoS One"},{"issue":"10","key":"9716_CR213","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 6(10):a016295","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"9716_CR214","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/CS20110340","volume":"122","author":"M Mihara","year":"2012","unstructured":"Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M (2012) IL-6\/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 122(4):143\u2013159","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"9716_CR215","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/0002-8703(93)90526-F","volume":"126","author":"Y Miyao","year":"1993","unstructured":"Miyao Y, Yasue H, Ogawa H, Misumi I, Masuda T, Sakamoto T, Morita E (1993) Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J 126(6):1299\u20131304","journal-title":"Am Heart J"},{"issue":"6","key":"9716_CR216","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00011-016-0931-4","volume":"65","author":"WM Jong","year":"2016","unstructured":"Jong WM, Ten Cate H, Linnenbank AC, de Boer OJ, Reitsma PH, de Winter RJ, Zuurbier CJ (2016) Reduced acute myocardial ischemia-reperfusion injury in IL-6-deficient mice employing a closed-chest model. Inflamm Res 65(6):489\u2013499","journal-title":"Inflamm Res"},{"issue":"12","key":"9716_CR217","doi-asserted-by":"publisher","first-page":"e0167195","DOI":"10.1371\/journal.pone.0167195","volume":"11","author":"MH Hartman","year":"2016","unstructured":"Hartman MH, Vreeswijk-Baudoin I, Groot HE, van de Kolk KW, de Boer RA, Mateo Leach I, Vliegenthart R, Sillje HH, van der Harst P (2016) Inhibition of interleukin-6 receptor in a murine model of myocardial ischemia-reperfusion. PLoS One 11(12):e0167195","journal-title":"PLoS One"},{"issue":"30","key":"9716_CR218","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","volume":"37","author":"O Kleveland","year":"2016","unstructured":"Kleveland O, Kunszt G, Bratlie M, Ueland T, Broch K, Holte E, Michelsen AE, Bendz B, Amundsen BH6, Espevik T9, Aakhus S10, Dam\u00e5s JK9, Aukrust P11, Wiseth R6, Gullestad L (2016) Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial. Eur Heart J 37(30):2406\u20132413","journal-title":"Eur Heart J"},{"issue":"19","key":"9716_CR219","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1136\/heartjnl-2016-310875","volume":"103","author":"E Holte","year":"2017","unstructured":"Holte E, Kleveland O, Ueland T, Kunszt G, Bratlie M, Broch K, Michelsen AE, Bendz B, Amundsen BH, Aakhus S, Dam\u00e5s JK, Gullestad L, Aukrust P, Wiseth R (2017) Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction. Heart 103(19):1521\u20131527","journal-title":"Heart"},{"issue":"8","key":"9716_CR220","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ejim.2004.07.013","volume":"15","author":"AS Gabriel","year":"2004","unstructured":"Gabriel AS, Martinsson A, Wretlind B, Ahnve S (2004) IL-6 levels in acute and post myocardial infarction: their relation to CRP levels, infarction size, left ventricular systolic function, and heart failure. Eur J Intern Med 15(8):523\u2013528","journal-title":"Eur J Intern Med"},{"issue":"1","key":"9716_CR221","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cardiores.2004.05.011","volume":"64","author":"B Dawn","year":"2004","unstructured":"Dawn B, Xuan YT, Guo Y, Rezazadeh A, Stein AB, Hunt G, Wu WJ, Tan W, Bolli R (2004) IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res 64(1):61\u201371","journal-title":"Cardiovasc Res"},{"issue":"5","key":"9716_CR222","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0002-9149(98)00388-9","volume":"82","author":"E Roig","year":"1998","unstructured":"Roig E, Or\u00fas J, Par\u00e9 C, Azqueta M, Filella X, Perez-Villa F, Heras M, Sanz G (1998) Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 82(5):688\u2013690","journal-title":"Am J Cardiol"},{"issue":"5","key":"9716_CR223","first-page":"253","volume":"39","author":"T Matsumura","year":"2002","unstructured":"Matsumura T, Tsushima K, Ohtaki E, Misu K, Tohbaru T, Asano R, Nagayama M, Kitahara K, Umemura J, Sumiyoshi T, Hosoda S (2002) Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy. J Cardiol 39(5):253\u2013257","journal-title":"J Cardiol"},{"issue":"4","key":"9716_CR224","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1055\/s-2007-1010227","volume":"46","author":"G Plenz","year":"1998","unstructured":"Plenz G, Song ZF, Reichenberg S, Tjan TD, Robenek H, Deng MC (1998) Left-ventricular expression of interleukin-6 messenger-RNA higher in idiopathic dilated than in ischemic cardiomyopathy. Thorac Cardiovasc Surg 46(4):213\u2013216","journal-title":"Thorac Cardiovasc Surg"},{"issue":"1","key":"9716_CR225","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijcard.2011.01.085","volume":"155","author":"LP Ma","year":"2012","unstructured":"Ma LP, Premaratne G, Bollano E, Lindholm C, Fu M (2012) Interleukin-6-deficient mice resist development of experimental autoimmune cardiomyopathy induced by immunization of \u03b21-adrenergic receptor. Int J Cardiol 155(1):20\u201325","journal-title":"Int J Cardiol"},{"issue":"1","key":"9716_CR226","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cyto.2014.12.024","volume":"74","author":"JA Fontes","year":"2015","unstructured":"Fontes JA, Rose NR, \u010cih\u00e1kov\u00e1 D (2015) The varying faces of IL-6: from cardiac protection to cardiac failure. Cytokine 74(1):62\u201368","journal-title":"Cytokine"},{"issue":"11","key":"9716_CR227","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","volume":"1843","author":"MD Turner","year":"2014","unstructured":"Turner MD, Nedjai B, Hurst T, Pennington DJ (2014) Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta 1843(11):2563\u20132582","journal-title":"Biochim Biophys Acta"},{"key":"9716_CR228","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ctrv.2017.08.004","volume":"60","author":"C Alfaro","year":"2017","unstructured":"Alfaro C, Sanmamed MF, Rodr\u00edguez-Ruiz ME, Teijeira \u00c1, O\u00f1ate C, Gonz\u00e1lez \u00c1, Ponz M, Schalper KA, P\u00e9rez-Gracia JL, Melero I (2017) Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treat Rev 60:24\u201331","journal-title":"Cancer Treat Rev"},{"key":"9716_CR229","doi-asserted-by":"publisher","first-page":"II428","DOI":"10.1161\/01.CIR.92.9.428","volume":"92","author":"MC Oz","year":"1995","unstructured":"Oz MC, Liao H, Naka Y, Seldomridge A, Becker DN, Michler RE, Smith CR, Rose EA, Stern DM, Pinsky DJ (1995) Ischemia-induced interleukin-8 release after human heart transplantation. A potential role for endothelial cells. Circulation 92:II428\u2013II432","journal-title":"Circulation"},{"issue":"2","key":"9716_CR230","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0022-5223(96)70458-0","volume":"111","author":"S Wan","year":"1996","unstructured":"Wan S, Marchant A, DeSmet JM, Antoine M, Zhang H, Vachiery JL, Goldman M, Vincent JL, LeClerc JL (1996) Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg 111(2):469\u2013477","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"9716_CR231","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/hrt.70.2.132","volume":"70","author":"Y Abe","year":"1993","unstructured":"Abe Y, Kawakami M, Kuroki M, Yamamoto T, Fujii M, Kobayashi H, Yaginuma T, Kashii A, Saito M, Matsushima K (1993) Transient rise in serum interleukin-8 concentration during acute myocardial infarction. Br Heart J 70(2):132\u2013134","journal-title":"Br Heart J"},{"issue":"3","key":"9716_CR232","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/hrt.2003.028092","volume":"91","author":"B Dybdahl","year":"2005","unstructured":"Dybdahl B, Sl\u00f8rdahl SA, Waage A, Kierulf P, Espevik T, Sundan A (2005) Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart 91(3):299\u2013304","journal-title":"Heart"},{"key":"9716_CR233","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ijcard.2016.07.073","volume":"221","author":"S Zarrouk-Mahjoub","year":"2016","unstructured":"Zarrouk-Mahjoub S, Zaghdoudi M, Amira Z, Chebi H, Khabouchi N, Finsterer J, Mechmeche R, Ghazouani E (2016) Pro- and anti-inflammatory cytokines in post-infarction left ventricular remodeling. Int J Cardiol 221:632\u2013636","journal-title":"Int J Cardiol"},{"key":"9716_CR234","doi-asserted-by":"crossref","unstructured":"Lu L, Wei P, Cao Y, Zhang Q, Liu M, Liu XD, Wang ZL, Zhang PY (2016) Effect of total peony glucoside pretreatment on NF-\u03baB and ICAM-1 expression in myocardial tissue of rat with myocardial ischemia-reperfusion injury. Genet Mol Res 15(4)","DOI":"10.4238\/gmr15048978"},{"issue":"1","key":"9716_CR235","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1172\/JCI117680","volume":"95","author":"GL Kukielka","year":"1995","unstructured":"Kukielka GL, Smith CW, LaRosa GJ, Manning AM, Mendoza LH, Daly TJ, Hughes BJ, Youker KA, Hawkins HK, Michael LH et al (1995) Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 95(1):89\u2013103","journal-title":"J Clin Invest"},{"issue":"6","key":"9716_CR236","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.3892\/etm.2017.5246","volume":"14","author":"L Hu","year":"2017","unstructured":"Hu L, Cai N, Jia H (2017) Pterostilbene attenuates myocardial ischemia-reperfusion injury via the phosphatidylinositol 3'-kinase-protein kinase B signaling pathway. Exp Ther Med 14(6):5509\u20135514","journal-title":"Exp Ther Med"},{"issue":"1","key":"9716_CR237","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0022-5223(98)70249-1","volume":"116","author":"EM Boyle Jr","year":"1998","unstructured":"Boyle EM Jr, Kovacich JC, H\u00e8bert CA, Canty TG Jr, Chi E, Morgan EN, Pohlman TH, Verrier ED (1998) Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury. J Thorac Cardiovasc Surg 116(1):114\u2013121","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"9716_CR238","doi-asserted-by":"publisher","first-page":"H542","DOI":"10.1152\/ajpheart.00089.2005","volume":"289","author":"R Ockaili","year":"2005","unstructured":"Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler AA 3rd, Kukreja RC (2005) HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am J Physiol Heart Circ Physiol 289(2):H542\u2013H548","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"9716_CR239","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.atherosclerosis.2015.08.022","volume":"242","author":"E Cavusoglu","year":"2015","unstructured":"Cavusoglu E, Marmur JD, Yanamadala S, Chopra V, Hegde S, Nazli A, Singh KP, Zhang M, Eng C (2015) Elevated baseline plasma IL-8 levels are an independent predictor of long-term all-cause mortality in patients with acute coronary syndrome. Atherosclerosis 242(2):589\u2013594","journal-title":"Atherosclerosis"},{"issue":"2","key":"9716_CR240","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cyto.2011.06.010","volume":"56","author":"X Zhang","year":"2011","unstructured":"Zhang X, Zhang B, Zhang M, Han Y, Zhao Y, Meng Z, Li X, Kang J, Yan C (2011) Interleukin-8 gene polymorphism is associated with acute coronary syndrome in the Chinese Han population. Cytokine 56(2):188\u2013191","journal-title":"Cytokine"},{"key":"9716_CR241","doi-asserted-by":"crossref","unstructured":"Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M, Ferrer J (2006) Prognostic value of interleukin-8 as a predictor of heart failure in patients with myocardial infarction and percutaneous intervention. Int J Cardiol 111(1):158-160.","DOI":"10.1016\/j.ijcard.2005.05.063"},{"issue":"11","key":"9716_CR242","doi-asserted-by":"publisher","first-page":"e112359","DOI":"10.1371\/journal.pone.0112359","volume":"9","author":"T Husebye","year":"2014","unstructured":"Husebye T, Eritsland J, Arnesen H, Bj\u00f8rnerheim R, Mangschau A, Seljeflot I, Andersen G\u00d8 (2014) Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure. PLoS One 9(11):e112359","journal-title":"PLoS One"},{"issue":"1","key":"9716_CR243","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijcard.2013.12.170","volume":"172","author":"IM Vel\u00e1squez","year":"2014","unstructured":"Vel\u00e1squez IM, Frumento P, Johansson K, Berglund A, de Faire U, Leander K, Gigante B (2014) Association of interleukin 8 with myocardial infarction: results from the Stockholm Heart Epidemiology Program. Int J Cardiol 172(1):173\u2013178","journal-title":"Int J Cardiol"},{"issue":"5","key":"9716_CR244","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.tcm.2005.06.005","volume":"15","author":"NG Frangogiannis","year":"2005","unstructured":"Frangogiannis NG, Entman ML (2005) Chemokines in myocardial ischemia. Trends Cardiovasc Med 15(5):163\u2013169","journal-title":"Trends Cardiovasc Med"},{"issue":"12","key":"9716_CR245","doi-asserted-by":"publisher","first-page":"8562","DOI":"10.3390\/ijms12128562","volume":"12","author":"N Haleagrahara","year":"2011","unstructured":"Haleagrahara N, Chakravarthi S, Mathews L (2011) Insulin like growth factor-1 (IGF-1) causes overproduction of IL-8, an angiogenic cytokine and stimulates neovascularization in isoproterenol-induced myocardial infarction in rats. Int J Mol Sci 12(12):8562\u20138574","journal-title":"Int J Mol Sci"},{"issue":"9","key":"9716_CR246","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/eurheartj\/ehi761","volume":"27","author":"K Sch\u00f6mig","year":"2006","unstructured":"Sch\u00f6mig K, Busch G, Steppich B, Sepp D, Kaufmann J, Stein A, Sch\u00f6mig A, Ott I (2006) Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. Eur Heart J 27(9):1032\u20131037","journal-title":"Eur Heart J"},{"issue":"4","key":"9716_CR247","doi-asserted-by":"publisher","first-page":"H590","DOI":"10.1152\/ajpheart.00571.2012","volume":"305","author":"X Zhao","year":"2013","unstructured":"Zhao X, Zhang W, Xing D, Li P, Fu J, Gong K, Hage FG, Oparil S, Chen YF (2013) Endothelial cells overexpressing IL-8 receptor reduce cardiac remodeling and dysfunction following myocardial infarction. Am J Physiol Heart Circ Physiol 305(4):H590\u2013H598","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"9716_CR248","doi-asserted-by":"publisher","first-page":"H106","DOI":"10.1152\/ajpheart.01327.2005","volume":"291","author":"K Kaur","year":"2006","unstructured":"Kaur K, Sharma AK, Singal PK (2006) Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 291(1):H106\u2013H113","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"9716_CR249","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/bja\/88.4.496","volume":"88","author":"SR Azab El","year":"2002","unstructured":"El Azab SR, Rosseel PM, de Lange JJ, Groeneveld AB, van Strik R, van Wijk EM, Scheffer GJ (2002) Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesth 88(4):496\u2013501","journal-title":"Br J Anaesth"},{"issue":"24","key":"9716_CR250","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/S0195-668X(03)00480-9","volume":"24","author":"S Adamopoulos","year":"2003","unstructured":"Adamopoulos S, Parissis JT, Paraskevaidis I, Karatzas D, Livanis E, Georgiadis M, Karavolias G, Mitropoulos D, Degiannis D, Kremastinos DT (2003) Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur Heart J 24(24):2186\u20132196","journal-title":"Eur Heart J"},{"issue":"6","key":"9716_CR251","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1142\/S0192415X15500627","volume":"43","author":"W Zhang","year":"2015","unstructured":"Zhang W, Xing B, Yang L, Shi J, Zhou X (2015) Icaritin attenuates myocardial ischemia and reperfusion injury via anti-inflammatory and anti-oxidative stress effects in rats. Am J Chin Med 43(6):1083\u20131097","journal-title":"Am J Chin Med"},{"key":"9716_CR252","doi-asserted-by":"publisher","first-page":"563951","DOI":"10.1155\/2015\/563951","volume":"2015","author":"C Chang","year":"2015","unstructured":"Chang C, Ji Q, Wu B, Yu K, Zeng Q, Xin S, Liu J, Zhou Y (2015) Chemerin 15-Ameliorated cardiac ischemia-reperfusion injury is associated with the induction of alternatively activated macrophages. Mediat Inflamm 2015:563951","journal-title":"Mediat Inflamm"},{"issue":"3","key":"9716_CR253","doi-asserted-by":"publisher","first-page":"337","DOI":"10.15252\/emmm.201606924","volume":"9","author":"L Cambier","year":"2017","unstructured":"Cambier L, de Couto G, Ibrahim A, Echavez AK, Valle J, Liu W, Kreke M, Smith RR, Marb\u00e1n L, Marb\u00e1n E (2017) Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL-10 expression and secretion. EMBO Mol Med 9(3):337\u2013352","journal-title":"EMBO Mol Med"},{"key":"9716_CR254","doi-asserted-by":"publisher","unstructured":"Chen H, Jing XY, Shen YJ, Wang TL, Ou C, Lu SF, Cai Y, Li Q, Ding YJ, Yu XC, Zhu BM (2018) Stat5-dependent cardioprotection in late remote ischemia preconditioning. Cardiovasc Res doi. https:\/\/doi.org\/10.1093\/cvr\/cvy014 [Epub ahead of print]","DOI":"10.1093\/cvr\/cvy014"},{"issue":"9","key":"9716_CR255","doi-asserted-by":"publisher","first-page":"e25009","DOI":"10.1371\/journal.pone.0025009","volume":"6","author":"S Dhingra","year":"2011","unstructured":"Dhingra S, Bagchi AK, Ludke AL, Sharma AK, Singal PK (2011) Akt regulates IL-10 mediated suppression of TNF\u03b1-induced cardiomyocyte apoptosis by upregulating Stat3 phosphorylation. PLoS One 6(9):e25009","journal-title":"PLoS One"},{"issue":"6","key":"9716_CR256","doi-asserted-by":"publisher","first-page":"H3524","DOI":"10.1152\/ajpheart.00919.2007","volume":"293","author":"S Dhingra","year":"2007","unstructured":"Dhingra S, Sharma AK, Singla DK, Singal PK (2007) p38 and ERK1\/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 293(6):H3524\u2013H3531","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"9716_CR257","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/cvr\/cvp040","volume":"82","author":"S Dhingra","year":"2009","unstructured":"Dhingra S, Sharma AK, Arora RC, Slezak J, Singal PK (2009) IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis. Cardiovasc Res 82(1):59\u201366","journal-title":"Cardiovasc Res"},{"issue":"1","key":"9716_CR258","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cyto.2012.10.013","volume":"61","author":"AK Bagchi","year":"2013","unstructured":"Bagchi AK, Sharma A, Dhingra S, Lehenbauer Ludke AR, Al-Shudiefat AA, Singal PK (2013) Interleukin-10 activates Toll-like receptor 4 and requires MyD88 for cardiomyocyte survival. Cytokine 61(1):304\u2013314","journal-title":"Cytokine"},{"issue":"6","key":"9716_CR259","doi-asserted-by":"publisher","first-page":"H1238","DOI":"10.1152\/ajpheart.00800.2016","volume":"312","author":"AK Bagchi","year":"2017","unstructured":"Bagchi AK, Akolkar G, Mandal S, Ayyappan P, Yang X, Singal PK (2017) Toll-like receptor 2 dominance over Toll-like receptor 4 in stressful conditions for its detrimental role in the heart. Am J Physiol Heart Circ Physiol 312(6):H1238\u2013H1247","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9716_CR260","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fphys.2015.00124","volume":"6","author":"V Kesherwani","year":"2015","unstructured":"Kesherwani V, Chavali V, Hackfort BT, Tyagi SC, Mishra PK (2015) Exercise ameliorates high fat diet induced cardiac dysfunction by increasing interleukin 10. Front Physiol 6:124","journal-title":"Front Physiol"},{"key":"9716_CR261","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1046\/j.1540-8191.18.s2.8.x","volume":"18","author":"A Ukimura","year":"2003","unstructured":"Ukimura A, Terasaki F, Fujioka S, Deguchi H, Kitaura Y, Isomura T, Suma H (2003) Quantitative analysis of cytokine mRNA expression in hearts from patients with nonischemic dilated cardiomyopathy (DCM). J Card Surg 18:S101\u2013S108","journal-title":"J Card Surg"},{"issue":"7","key":"9716_CR262","first-page":"8107","volume":"8","author":"Y Guo","year":"2015","unstructured":"Guo Y, Cen Z, Wei B, Wu W, Zhou Q (2015) Increased circulating interleukin 10-secreting B cells in patients with dilated cardiomyopathy. Int J Clin Exp Pathol 8(7):8107\u20138114","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"9716_CR263","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00059-012-3661-6","volume":"37","author":"T Izumi","year":"2012","unstructured":"Izumi T, Nishii M (2012) Diagnostic and prognostic biomarkers in acute myocarditis. Interleukin-10. Herz 37(6):627\u2013631","journal-title":"Herz"},{"key":"9716_CR264","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2016.09.012","volume":"254","author":"F Santoro","year":"2016","unstructured":"Santoro F, Tarantino N, Ferraretti A, Ieva R, Musaico F, Guastafierro F, Di Martino L, Di Biase M, Brunetti ND (2016) Serum interleukin 6 and 10 levels in Takotsubo cardiomyopathy: increased admission levels may predict adverse events at follow-up. Atherosclerosis 254:28\u201334","journal-title":"Atherosclerosis"},{"issue":"6","key":"9716_CR265","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/heart.84.6.668","volume":"84","author":"Y Seta","year":"2000","unstructured":"Seta Y, Kanda T, Tanaka T, Arai M, Sekiguchi K, Yokoyama T, Kurimoto M, Tamura J, Kurabayashi M (2000) Interleukin 18 in acute myocardial infarction. Heart 84(6):668","journal-title":"Heart"},{"issue":"7","key":"9716_CR266","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/01.mca.0000176991.55999.b4","volume":"16","author":"D Kawasaki","year":"2005","unstructured":"Kawasaki D, Tsujino T, Morimoto S, Masai M, Masutani M, Ohyanagi M, Kashiwamura S, Okamura H, Masuyama T (2005) Plasma interleukin-18 concentration: a novel marker of myocardial ischemia rather than necrosis in humans. Coron Artery Dis 16(7):437\u2013441","journal-title":"Coron Artery Dis"},{"issue":"1","key":"9716_CR267","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1054\/jcaf.2002.31628","volume":"8","author":"M Yamaoka-Tojo","year":"2002","unstructured":"Yamaoka-Tojo M, Tojo T, Inomata T, Machida Y, Osada K, Izumi T (2002) Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1\/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. J Card Fail 8(1):21\u201327","journal-title":"J Card Fail"},{"issue":"1","key":"9716_CR268","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0008-6363(03)00339-0","volume":"59","author":"PR Woldbaek","year":"2003","unstructured":"Woldbaek PR, T\u00f8nnessen T, Henriksen UL, Florholmen G, Lunde PK, Lyberg T, Christensen G (2003) Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction. Cardiovasc Res 59(1):122\u2013131","journal-title":"Cardiovasc Res"},{"issue":"14","key":"9716_CR269","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1096\/fj.04-2426fje","volume":"18","author":"Z Mallat","year":"2004","unstructured":"Mallat Z, Heymes C, Corbaz A, Logeart D, Alouani S, Cohen-Solal A, Seidler T, Hasenfuss G, Chvatchko Y, Shah AM, Tedgui A (2004) Evidence for altered interleukin 18 (IL)-18 pathway in human heart failure. FASEB J 18(14):1752\u20131754","journal-title":"FASEB J"},{"key":"9716_CR270","doi-asserted-by":"crossref","unstructured":"Dinarello CA (2001) Novel targets for interleukin 18 binding protein. Ann Rheum Dis 60 Suppl 3:iii18-24.","DOI":"10.1136\/ard.60.90003.iii18"},{"issue":"12","key":"9716_CR271","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/tri.12683","volume":"28","author":"H Gu","year":"2015","unstructured":"Gu H, Xie M, Xu L, Zheng X, Yang Y, Lv X (2015) The protective role of interleukin-18 binding protein in a murine model of cardiac ischemia\/reperfusion injury. Transpl Int 28(12):1436\u20131444","journal-title":"Transpl Int"},{"issue":"12","key":"9716_CR272","doi-asserted-by":"publisher","first-page":"7853","DOI":"10.1074\/jbc.M808824200","volume":"284","author":"K Venkatachalam","year":"2009","unstructured":"Venkatachalam K, Prabhu SD, Reddy VS, Boylston WH, Valente AJ, Chandrasekar B (2009) Neutralization of interleukin-18 ameliorates ischemia\/reperfusion-induced myocardial injury. J Biol Chem 284(12):7853\u20137865","journal-title":"J Biol Chem"},{"issue":"1-2","key":"9716_CR273","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2119\/2007-00058.Westphal","volume":"14","author":"E Westphal","year":"2008","unstructured":"Westphal E, Rohrbach S, Buerke M, Behr H, Darmer D, Silber RE, Werdan K, Loppnow H (2008) Altered interleukin-1 receptor antagonist and interleukin-18 mRNA expression in myocardial tissues of patients with dilatated cardiomyopathy. Mol Med 14(1-2):55\u201363","journal-title":"Mol Med"},{"issue":"12","key":"9716_CR274","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1006\/jmcc.2000.1242","volume":"32","author":"T Kanda","year":"2000","unstructured":"Kanda T, Tanaka T, Sekiguchi K, Seta Y, Kurimoto M, Wilson McManus JE, Nagai R, Yang D, McManus BM, Kobayashi I (2000) Effect of interleukin-18 on viral myocarditis: enhancement of interferon- gamma and natural killer cell activity. J Mol Cell Cardiol 32(12):2163\u20132171","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"9716_CR275","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S0024-3205(01)01509-0","volume":"70","author":"A Yoshida","year":"2002","unstructured":"Yoshida A, Kand T, Tanaka T, Yokoyama T, Kurimoto M, Tamura J, Kobayashi I (2002) Interleukin-18 reduces expression of cardiac tumor necrosis factor-alpha and atrial natriuretic peptide in a murine model of viral myocarditis. Life Sci 70(11):1225\u20131234","journal-title":"Life Sci"},{"issue":"9","key":"9716_CR276","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1006\/jmcc.2001.1416","volume":"33","author":"B Gl\u00fcck","year":"2001","unstructured":"Gl\u00fcck B, Schmidtke M, Merkle I, Stelzner A, Gemsa D (2001) Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice. J Mol Cell Cardiol 33(9):1615\u20131626","journal-title":"J Mol Cell Cardiol"},{"issue":"9","key":"9716_CR277","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.4049\/jimmunol.170.9.4731","volume":"170","author":"D Fairweather","year":"2003","unstructured":"Fairweather D, Yusung S, Frisancho S, Barrett M, Gatewood S, Steele R, Rose NR (2003) IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication. J Immunol 170(9):4731\u20134737","journal-title":"J Immunol"},{"issue":"6","key":"9716_CR278","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.micinf.2014.03.007","volume":"16","author":"L Esper","year":"2014","unstructured":"Esper L, Utsch L, Soriani FM, Brant F, Esteves Arantes RM, Campos CF, Pinho V, Souza DG, Teixeira MM, Tanowitz HB, Vieira LQ, Machado FS (2014) Regulatory effects of IL-18 on cytokine profiles and development of myocarditis during Trypanosoma cruzi infection. Microbes Infect 16(6):481\u2013490","journal-title":"Microbes Infect"},{"issue":"11","key":"9716_CR279","first-page":"828","volume":"38","author":"GP Hout van","year":"2017","unstructured":"van Hout GP, Bosch L, Ellenbroek GH, de Haan JJ, van Solinge WW, Cooper MA, Arslan F, de Jager SC, Robertson AA, Pasterkamp G, Hoefer IE (2017) The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction. Eur Heart J 38(11):828\u2013836","journal-title":"Eur Heart J"},{"issue":"10","key":"9716_CR280","first-page":"1908","volume":"7","author":"Z Su","year":"2015","unstructured":"Su Z, Lin R, Chen Y, Shu X, Zhang H, Nie R, Wang J, Xie S (2015) Knockdown of EMMPRIN improves adverse remodeling mediated by IL-18 in the post-infarcted heart. Am J Transl Res 7(10):1908\u20131916","journal-title":"Am J Transl Res"},{"key":"9716_CR281","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","volume":"226","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Zhang X (2008) Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226:205\u2013218","journal-title":"Immunol Rev"},{"issue":"2","key":"9716_CR282","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10741-008-9104-z","volume":"14","author":"K Kaur","year":"2009","unstructured":"Kaur K, Dhingra S, Slezak J, Sharma AK, Bajaj A, Singal PK (2009) Biology of TNFalpha and IL-10, and their imbalance in heart failure. Heart Fail Rev 14(2):113\u2013123","journal-title":"Heart Fail Rev"},{"issue":"10","key":"9716_CR283","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/01.RES.0000249405.13536.49","volume":"99","author":"SA Huber","year":"2006","unstructured":"Huber SA, Feldman AM, Sartini D (2006) Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice. Circ Res 99(10):1109\u20131116","journal-title":"Circ Res"},{"issue":"3","key":"9716_CR284","first-page":"483","volume":"11","author":"CA Dinarello","year":"2000","unstructured":"Dinarello CA (2000) Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 11(3):483\u2013486","journal-title":"Eur Cytokine Netw"},{"issue":"3","key":"9716_CR285","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00109-001-0307-1","volume":"80","author":"F Biet","year":"2002","unstructured":"Biet F, Locht C, Kremer L (2002) Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med 80(3):147\u2013162","journal-title":"J Mol Med"},{"issue":"4","key":"9716_CR286","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S0006-291X(03)00496-0","volume":"303","author":"B Chandrasekar","year":"2003","unstructured":"Chandrasekar B, Colston JT, de la Rosa SD, Rao PP, Freeman GL (2003) TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation. Biochem Biophys Res Commun 303(4):1152\u20131158","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"9716_CR287","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/heart.88.5.467","volume":"88","author":"Z Mallat","year":"2002","unstructured":"Mallat Z, Henry P, Fressonnet R, Alouani S, Scoazec A, Beaufils P, Chvatchko Y, Tedgui A (2002) Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart 88(5):467\u2013469","journal-title":"Heart"},{"issue":"3","key":"9716_CR288","first-page":"177","volume":"16","author":"H Suchanek","year":"2005","unstructured":"Suchanek H, My\u015bliwska J, Siebert J, Wieckiewicz J, Hak \u0141, Szyndler K, Kartanowicz D (2005) High serum interleukin-18 concentrations in patients with coronary artery disease and type 2 diabetes mellitus. Eur Cytokine Netw 16(3):177\u2013185","journal-title":"Eur Cytokine Netw"},{"issue":"20","key":"9716_CR289","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1161\/01.CIR.0000099509.76044.A2","volume":"108","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg S, Luc G, Ducimeti\u00e8re P, Arveiler D, Ferri\u00e8res J, Amouyel P, Evans A, Cambien F, Tiret L, PRIME Study Group (2003) Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 108(20):2453\u20132459","journal-title":"Circulation"},{"issue":"12","key":"9716_CR290","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1161\/01.ATV.0000248096.62495.73","volume":"26","author":"W Koenig","year":"2006","unstructured":"Koenig W, Khuseyinova N, Baumert J, Thorand B, Loewel H, Chambless L, Meisinger C, Schneider A, Martin S, Kolb H, Herder C (2006) Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA\/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol 26(12):2745\u20132751","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"9716_CR291","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cyto.2012.10.010","volume":"61","author":"BJ Jefferis","year":"2013","unstructured":"Jefferis BJ, Whincup PH, Welsh P, Wannamethee SG, Rumley A, Ebrahim S, Lawlor DA, Lowe GD (2013) Prospective study of IL-18 and risk of MI and stroke in men and women aged 60-79 years: a nested case-control study. Cytokine 61(2):513\u2013520","journal-title":"Cytokine"},{"issue":"5","key":"9716_CR292","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1089\/met.2015.0130","volume":"14","author":"TB Opstad","year":"2016","unstructured":"Opstad TB, Arnesen H, Pettersen A\u00c5, Seljeflot I (2016) Combined elevated levels of the proinflammatory cytokines IL-18 and IL-12 are associated with clinical events in patients with coronary artery disease: an observational study. Metab Syndr Relat Disord 14(5):242\u2013248","journal-title":"Metab Syndr Relat Disord"},{"issue":"9","key":"9716_CR293","doi-asserted-by":"publisher","first-page":"e74498","DOI":"10.1371\/journal.pone.0074498","volume":"8","author":"TB Opstad","year":"2013","unstructured":"Opstad TB, Pettersen A\u00c5, Arnesen H, Seljeflot I (2013) The co-existence of the IL-18+183 A\/G and MMP-9 -1562 C\/T polymorphisms is associated with clinical events in coronary artery disease patients. PLoS One 8(9):e74498","journal-title":"PLoS One"},{"key":"9716_CR294","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mehy.2017.05.009","volume":"104","author":"S Jadranko","year":"2017","unstructured":"Jadranko S, Tokmadzic VS, Danijel K, Igor M, Nada VD, Sanja B, Marijana R, Ana LB, Gordana L (2017) Endothelial dysfunction mediated by interleukin-18 in patients with ischemic heart disease undergoing coronary artery bypass grafting surgery. Med Hypotheses 104:20\u201324","journal-title":"Med Hypotheses"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-018-9716-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-018-9716-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-018-9716-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T23:21:12Z","timestamp":1751671272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-018-9716-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":294,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["9716"],"URL":"https:\/\/doi.org\/10.1007\/s10741-018-9716-x","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]},"assertion":[{"value":"4 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}